<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:BKHAU="http://BKHAU/20251130"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2025"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="bkhau-20251130.xsd" xlink:type="simple"/>
    <context id="From2024-12-01to2025-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-11-30</endDate>
        </period>
    </context>
    <context id="From2024-12-012025-11-30_custom_UnitsEachConsistingOfOneOrdinaryShare0.0001ParValueAndOnefifth15OfOneRightEntitlingHolderThereofToReceiveOneClassOrdinaryShareUponConsummationOfOurInitialBusinessCombinationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BKHAU:UnitsEachConsistingOfOneOrdinaryShare0.0001ParValueAndOnefifth15OfOneRightEntitlingHolderThereofToReceiveOneClassOrdinaryShareUponConsummationOfOurInitialBusinessCombinationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-11-30</endDate>
        </period>
    </context>
    <context id="From2024-12-012025-11-30_custom_OrdinarySharesParValue0.0001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BKHAU:OrdinarySharesParValue0.0001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-11-30</endDate>
        </period>
    </context>
    <context id="From2024-12-012025-11-30_custom_RightsEachRightEntitlingHolderToReceiveOneClassOrdinaryShareUponConsummationOfOurInitialBusinessCombinationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BKHAU:RightsEachRightEntitlingHolderToReceiveOneClassOrdinaryShareUponConsummationOfOurInitialBusinessCombinationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-11-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
        </entity>
        <period>
            <instant>2025-05-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-06">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
        </entity>
        <period>
            <instant>2026-03-06</instant>
        </period>
    </context>
    <context id="AsOf2025-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
        </entity>
        <period>
            <instant>2025-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2025-11-30_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="From2023-12-012024-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
        </entity>
        <period>
            <startDate>2023-12-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-11-30_custom_ClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BKHAU:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_custom_ClassBOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BKHAU:ClassBOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2023-11-30_custom_ClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BKHAU:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <context id="AsOf2023-11-30_custom_ClassBOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BKHAU:ClassBOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <context id="AsOf2023-11-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <context id="AsOf2023-11-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <context id="AsOf2023-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <context id="From2024-12-012025-11-30_custom_ClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BKHAU:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-11-30</endDate>
        </period>
    </context>
    <context id="From2024-12-012025-11-30_custom_ClassBOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BKHAU:ClassBOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-11-30</endDate>
        </period>
    </context>
    <context id="From2024-12-012025-11-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-11-30</endDate>
        </period>
    </context>
    <context id="From2024-12-012025-11-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-11-30</endDate>
        </period>
    </context>
    <context id="From2023-12-012024-11-30_custom_ClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BKHAU:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2023-12-012024-11-30_custom_ClassBOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BKHAU:ClassBOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2023-12-012024-11-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2023-12-012024-11-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-11-30_custom_ClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BKHAU:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-30</instant>
        </period>
    </context>
    <context id="AsOf2025-11-30_custom_ClassBOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BKHAU:ClassBOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-30</instant>
        </period>
    </context>
    <context id="AsOf2025-11-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-30</instant>
        </period>
    </context>
    <context id="AsOf2025-11-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-30</instant>
        </period>
    </context>
    <context id="From2024-03-012024-03-22_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-22</endDate>
        </period>
    </context>
    <context id="AsOf2024-03-22_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-22</instant>
        </period>
    </context>
    <context id="From2024-03-012024-03-22_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-22</endDate>
        </period>
    </context>
    <context id="AsOf2024-03-22_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-22</instant>
        </period>
    </context>
    <context id="From2024-03-012024-03-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-22</endDate>
        </period>
    </context>
    <context id="AsOf2025-11-30_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-30</instant>
        </period>
    </context>
    <context id="AsOf2025-11-30_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-30</instant>
        </period>
    </context>
    <context id="From2024-12-012025-11-30_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-11-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
        </entity>
        <period>
            <instant>2025-03-15</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-07-07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
        </entity>
        <period>
            <instant>2025-07-07</instant>
        </period>
    </context>
    <context id="AsOf2025-07-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
        </entity>
        <period>
            <instant>2025-07-08</instant>
        </period>
    </context>
    <context id="From2024-12-012025-11-30_custom_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BKHAU:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-11-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-11-30_custom_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BKHAU:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
        </entity>
        <period>
            <instant>2025-06-22</instant>
        </period>
    </context>
    <context id="AsOf2025-07-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
        </entity>
        <period>
            <instant>2025-07-15</instant>
        </period>
    </context>
    <context id="AsOf2025-11-30_us-gaap_CashEquivalentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_us-gaap_CashEquivalentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="From2024-12-012025-11-30_custom_RedeemableSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BKHAU:RedeemableSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-11-30</endDate>
        </period>
    </context>
    <context id="From2024-12-012025-11-30_custom_NonRedeemableSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BKHAU:NonRedeemableSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-11-30</endDate>
        </period>
    </context>
    <context id="From2023-12-012024-11-30_custom_RedeemableSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BKHAU:RedeemableSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2023-12-012024-11-30_custom_NonRedeemableSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BKHAU:NonRedeemableSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2023-10-012023-10-16_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BKHAU:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-10-16</endDate>
        </period>
    </context>
    <context id="AsOf2023-10-16_custom_SponsorMember_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BKHAU:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-16</instant>
        </period>
    </context>
    <context id="From2023-10-012023-10-16_custom_FounderSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BKHAU:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-10-16</endDate>
        </period>
    </context>
    <context id="AsOf2023-10-16_custom_FounderSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BKHAU:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-16</instant>
        </period>
    </context>
    <context id="From2023-10-012023-10-16_custom_FounderSharesMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BKHAU:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-10-16</endDate>
        </period>
    </context>
    <context id="From2024-03-012024-03-18_custom_FounderSharesMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BKHAU:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-18</endDate>
        </period>
    </context>
    <context id="From2024-03-012024-03-18_custom_FounderSharesMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BKHAU:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-18</endDate>
        </period>
    </context>
    <context id="From2024-03-012024-03-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-20</endDate>
        </period>
    </context>
    <context id="AsOf2024-03-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
        </entity>
        <period>
            <instant>2024-03-20</instant>
        </period>
    </context>
    <context id="AsOf2023-10-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
        </entity>
        <period>
            <instant>2023-10-16</instant>
        </period>
    </context>
    <context id="AsOf2025-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="AsOf2025-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
        </entity>
        <period>
            <instant>2025-08-31</instant>
        </period>
    </context>
    <context id="From2024-12-012025-11-30_custom_JuneConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">BKHAU:JuneConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-11-30</endDate>
        </period>
    </context>
    <context id="From2024-12-012025-09-30_custom_ConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">BKHAU:ConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2024-12-012025-06-13_custom_ConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">BKHAU:ConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-06-13</endDate>
        </period>
    </context>
    <context id="AsOf2025-09-30_custom_ConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">BKHAU:ConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="AsOf2025-08-31_custom_ConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">BKHAU:ConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-31</instant>
        </period>
    </context>
    <context id="From2024-12-012025-11-30_custom_ConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">BKHAU:ConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-11-30</endDate>
        </period>
    </context>
    <context id="From2024-12-012025-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2024-12-012025-09-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-09-23</endDate>
        </period>
    </context>
    <context id="From2024-12-012025-11-30_custom_SeptemberConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">BKHAU:SeptemberConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-11-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-13_custom_ConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">BKHAU:ConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-13</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_custom_ConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">BKHAU:ConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2025-09-23_custom_SeptemberConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">BKHAU:SeptemberConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-23</instant>
        </period>
    </context>
    <context id="AsOf2025-09-30_custom_SeptemberConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">BKHAU:SeptemberConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="From2024-12-012025-09-23_custom_SeptemberConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">BKHAU:SeptemberConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-09-23</endDate>
        </period>
    </context>
    <context id="From2024-12-012025-09-30_custom_SeptemberConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">BKHAU:SeptemberConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-11-30_custom_SeptemberConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">BKHAU:SeptemberConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="From2024-03-012024-03-22_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-22</endDate>
        </period>
    </context>
    <context id="From2024-12-012025-11-30_custom_ProposedPublicOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">BKHAU:ProposedPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-11-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-11-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-30</instant>
        </period>
    </context>
    <context id="From2024-03-012024-03-18_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-18</endDate>
        </period>
    </context>
    <context id="From2024-03-012024-03-18_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-18</endDate>
        </period>
    </context>
    <context id="AsOf2025-11-30_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-30</instant>
        </period>
    </context>
    <context id="AsOf2025-11-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-30</instant>
        </period>
    </context>
    <context id="AsOf2025-11-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-30</instant>
        </period>
    </context>
    <context id="AsOf2025-11-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-12-012026-02-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2026-02-28</endDate>
        </period>
    </context>
    <context id="AsOf2026-02-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
        </entity>
        <period>
            <instant>2026-02-12</instant>
        </period>
    </context>
    <context id="AsOf2026-01-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000775</identifier>
        </entity>
        <period>
            <instant>2026-01-22</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2024-12-01to2025-11-30" id="Fact000003">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="From2024-12-01to2025-11-30" id="Fact000004">2025</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2024-12-01to2025-11-30" id="Fact000005">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="From2024-12-01to2025-11-30" id="Fact000006">0002000775</dei:EntityCentralIndexKey>
    <BKHAU:AccruedInterestExpenses
      contextRef="AsOf2024-11-30"
      id="xdx2ixbrl0093"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2024-11-30"
      id="xdx2ixbrl0154"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestExpense
      contextRef="From2023-12-012024-11-30"
      id="xdx2ixbrl0184"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:ChangeInFairValueOfDerivativeLiability
      contextRef="From2023-12-012024-11-30"
      id="xdx2ixbrl0187"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-11-30_custom_ClassBOrdinarySharesMember"
      id="xdx2ixbrl0208"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-11-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0209"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-11-30_custom_ClassBOrdinarySharesMember"
      id="xdx2ixbrl0213"
      unitRef="Shares"
      xsi:nil="true"/>
    <BKHAU:RemeasurementOfCommonStockSubjectToPossibleRedemption
      contextRef="From2024-12-012025-11-30_custom_ClassAOrdinarySharesMember"
      id="xdx2ixbrl0215"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:RemeasurementOfCommonStockSubjectToPossibleRedemption
      contextRef="From2024-12-012025-11-30_custom_ClassBOrdinarySharesMember"
      id="xdx2ixbrl0216"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:RemeasurementOfCommonStockSubjectToPossibleRedemption
      contextRef="From2024-12-012025-11-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0217"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:ReclassificationOfDerivativeLossToApic
      contextRef="From2024-12-012025-11-30_custom_ClassAOrdinarySharesMember"
      id="xdx2ixbrl0221"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:ReclassificationOfDerivativeLossToApic
      contextRef="From2024-12-012025-11-30_custom_ClassBOrdinarySharesMember"
      id="xdx2ixbrl0222"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:ReclassificationOfDerivativeLossToApic
      contextRef="From2024-12-012025-11-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0224"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2024-12-012025-11-30_custom_ClassAOrdinarySharesMember"
      id="xdx2ixbrl0227"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2024-12-012025-11-30_custom_ClassBOrdinarySharesMember"
      id="xdx2ixbrl0228"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2024-12-012025-11-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0229"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-11-30_custom_ClassBOrdinarySharesMember"
      id="xdx2ixbrl0234"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-11-30_custom_ClassBOrdinarySharesMember"
      id="xdx2ixbrl0241"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-11-30_custom_ClassAOrdinarySharesMember"
      id="xdx2ixbrl0243"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-11-30_custom_ClassAOrdinarySharesMember"
      id="xdx2ixbrl0249"
      unitRef="Shares"
      xsi:nil="true"/>
    <BKHAU:ProceedsFromSaleOfIpoUnits
      contextRef="From2023-12-012024-11-30_custom_ClassBOrdinarySharesMember"
      id="xdx2ixbrl0254"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:ProceedsFromSaleOfIpoUnits
      contextRef="From2023-12-012024-11-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0256"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:ProceedsFromSaleOfPrivatePlacementUnits
      contextRef="From2023-12-012024-11-30_custom_ClassBOrdinarySharesMember"
      id="xdx2ixbrl0262"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:ProceedsFromSaleOfPrivatePlacementUnits
      contextRef="From2023-12-012024-11-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0264"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:IssuanceOfRepresentativeShares
      contextRef="From2023-12-012024-11-30_custom_ClassBOrdinarySharesMember"
      id="xdx2ixbrl0270"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:IssuanceOfRepresentativeShares
      contextRef="From2023-12-012024-11-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0272"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:CommonStockSubjectToPossibleRedemption
      contextRef="From2023-12-012024-11-30_custom_ClassBOrdinarySharesMember"
      id="xdx2ixbrl0278"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:CommonStockSubjectToPossibleRedemption
      contextRef="From2023-12-012024-11-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0280"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:ConversionOfClassBToClassOrdinaryShares
      contextRef="From2023-12-012024-11-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0287"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:ConversionOfClassBToClassOrdinaryShares
      contextRef="From2023-12-012024-11-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0288"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:ConversionOfClassBToClassOrdinaryShares
      contextRef="From2023-12-012024-11-30"
      id="xdx2ixbrl0289"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:UnderwriterCommissions
      contextRef="From2023-12-012024-11-30_custom_ClassAOrdinarySharesMember"
      id="xdx2ixbrl0295"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:UnderwriterCommissions
      contextRef="From2023-12-012024-11-30_custom_ClassBOrdinarySharesMember"
      id="xdx2ixbrl0296"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:UnderwriterCommissions
      contextRef="From2023-12-012024-11-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0298"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:OfferingCosts
      contextRef="From2023-12-012024-11-30_custom_ClassAOrdinarySharesMember"
      id="xdx2ixbrl0301"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:OfferingCosts
      contextRef="From2023-12-012024-11-30_custom_ClassBOrdinarySharesMember"
      id="xdx2ixbrl0302"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:AccretionOfAdditionalPaidInCapitalToAccumulatedDeficit
      contextRef="From2023-12-012024-11-30_custom_ClassAOrdinarySharesMember"
      id="xdx2ixbrl0307"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:AccretionOfAdditionalPaidInCapitalToAccumulatedDeficit
      contextRef="From2023-12-012024-11-30_custom_ClassBOrdinarySharesMember"
      id="xdx2ixbrl0308"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:AccretionOfAdditionalPaidInCapitalToAccumulatedDeficit
      contextRef="From2023-12-012024-11-30"
      id="xdx2ixbrl0311"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:RemeasurementOfCommonStockSubjectToPossibleRedemption
      contextRef="From2023-12-012024-11-30_custom_ClassAOrdinarySharesMember"
      id="xdx2ixbrl0313"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:RemeasurementOfCommonStockSubjectToPossibleRedemption
      contextRef="From2023-12-012024-11-30_custom_ClassBOrdinarySharesMember"
      id="xdx2ixbrl0314"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:RemeasurementOfCommonStockSubjectToPossibleRedemption
      contextRef="From2023-12-012024-11-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0315"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-12-012024-11-30_custom_ClassAOrdinarySharesMember"
      id="xdx2ixbrl0319"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-12-012024-11-30_custom_ClassBOrdinarySharesMember"
      id="xdx2ixbrl0320"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-12-012024-11-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0321"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-11-30_custom_ClassBOrdinarySharesMember"
      id="xdx2ixbrl0326"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-11-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0327"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-11-30_custom_ClassBOrdinarySharesMember"
      id="xdx2ixbrl0333"
      unitRef="Shares"
      xsi:nil="true"/>
    <BKHAU:ChangeInFairValueOfDerivativeLiabilities
      contextRef="From2023-12-012024-11-30"
      id="xdx2ixbrl0348"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsForPurchaseOfOtherAssets1
      contextRef="From2024-12-01to2025-11-30"
      id="xdx2ixbrl0365"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:CashDepositedInTrustAccount
      contextRef="From2023-12-012024-11-30"
      id="xdx2ixbrl0369"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:CashWithdrawanFromTrustToPayRedeemedPublicShareholders
      contextRef="From2023-12-012024-11-30"
      id="xdx2ixbrl0372"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:ProceedsFromIssuanceOfPromissoryNoteToRelatedParty
      contextRef="From2023-12-012024-11-30"
      id="xdx2ixbrl0381"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:ProceedsFromDueToTargetCompany
      contextRef="From2023-12-012024-11-30"
      id="xdx2ixbrl0384"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2024-12-01to2025-11-30"
      id="xdx2ixbrl0386"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2024-12-01to2025-11-30"
      id="xdx2ixbrl0389"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2024-12-01to2025-11-30"
      id="xdx2ixbrl0392"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2024-12-01to2025-11-30"
      id="xdx2ixbrl0395"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfOtherDebt
      contextRef="From2024-12-01to2025-11-30"
      id="xdx2ixbrl0398"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2024-12-01to2025-11-30"
      id="xdx2ixbrl0401"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="From2024-12-01to2025-11-30"
      id="xdx2ixbrl0404"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsOfOrdinaryDividends
      contextRef="From2023-12-012024-11-30"
      id="xdx2ixbrl0408"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:IssuanceOfConvertibleNoteRecognitionOfDerivativeLiability
      contextRef="From2023-12-012024-11-30"
      id="xdx2ixbrl0426"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:ReclassificationOfDerivativeLiabilityToApic
      contextRef="From2023-12-012024-11-30"
      id="xdx2ixbrl0429"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2024-12-01to2025-11-30"
      id="xdx2ixbrl0431"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:InitialClassificationOfCommonStockSubjectToPossibleRedemption
      contextRef="From2024-12-01to2025-11-30"
      id="xdx2ixbrl0434"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:AccretionsOfAdditionalPaidInCapitalToAccumulatedDeficit
      contextRef="From2024-12-01to2025-11-30"
      id="xdx2ixbrl0437"
      unitRef="USD"
      xsi:nil="true"/>
    <BKHAU:DeferredUnderwritingFeePayable
      contextRef="From2024-12-01to2025-11-30"
      id="xdx2ixbrl0443"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-11-30_custom_ConvertibleNoteMember"
      id="xdx2ixbrl0729"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-11-30_custom_SeptemberConvertibleNoteMember"
      id="xdx2ixbrl0785"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2025-11-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember"
      id="xdx2ixbrl0848"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2025-11-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      id="xdx2ixbrl0850"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-11-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember"
      id="xdx2ixbrl0856"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-11-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      id="xdx2ixbrl0858"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2024-12-01to2025-11-30" id="Fact000012">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="From2024-12-01to2025-11-30" id="Fact000013">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2024-12-01to2025-11-30" id="Fact000014">2025-11-30</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="From2024-12-01to2025-11-30" id="Fact000015">--11-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="From2024-12-01to2025-11-30" id="Fact000016">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2024-12-01to2025-11-30" id="Fact000017">001-41667</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2024-12-01to2025-11-30" id="Fact000018">Black Hawk Acquisition Corporation</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2024-12-01to2025-11-30" id="Fact000019">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2024-12-01to2025-11-30" id="Fact000020">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2024-12-01to2025-11-30" id="Fact000021">125 Blackhawk Plaza Circle</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2024-12-01to2025-11-30" id="Fact000022">Suite 166</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2024-12-01to2025-11-30" id="Fact000023">Danville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2024-12-01to2025-11-30" id="Fact000024">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2024-12-01to2025-11-30" id="Fact000025">94506</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2024-12-01to2025-11-30" id="Fact000026">(915)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2024-12-01to2025-11-30" id="Fact000027">217-4482</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="From2024-12-012025-11-30_custom_UnitsEachConsistingOfOneOrdinaryShare0.0001ParValueAndOnefifth15OfOneRightEntitlingHolderThereofToReceiveOneClassOrdinaryShareUponConsummationOfOurInitialBusinessCombinationMember"
      id="Fact000028">Units, each consisting of one ordinary share, $0.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2024-12-012025-11-30_custom_UnitsEachConsistingOfOneOrdinaryShare0.0001ParValueAndOnefifth15OfOneRightEntitlingHolderThereofToReceiveOneClassOrdinaryShareUponConsummationOfOurInitialBusinessCombinationMember"
      id="Fact000029">BKHAU</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2024-12-012025-11-30_custom_UnitsEachConsistingOfOneOrdinaryShare0.0001ParValueAndOnefifth15OfOneRightEntitlingHolderThereofToReceiveOneClassOrdinaryShareUponConsummationOfOurInitialBusinessCombinationMember"
      id="Fact000030">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2024-12-012025-11-30_custom_OrdinarySharesParValue0.0001PerShareMember"
      id="Fact000031">Ordinary shares, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2024-12-012025-11-30_custom_OrdinarySharesParValue0.0001PerShareMember"
      id="Fact000032">BKHA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2024-12-012025-11-30_custom_OrdinarySharesParValue0.0001PerShareMember"
      id="Fact000033">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2024-12-012025-11-30_custom_RightsEachRightEntitlingHolderToReceiveOneClassOrdinaryShareUponConsummationOfOurInitialBusinessCombinationMember"
      id="Fact000034">Rights, each right entitling the holder to receive one Class A ordinary share upon the consummation of our initial business combination</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2024-12-012025-11-30_custom_RightsEachRightEntitlingHolderToReceiveOneClassOrdinaryShareUponConsummationOfOurInitialBusinessCombinationMember"
      id="Fact000035">BKHAR</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2024-12-012025-11-30_custom_RightsEachRightEntitlingHolderToReceiveOneClassOrdinaryShareUponConsummationOfOurInitialBusinessCombinationMember"
      id="Fact000036">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2024-12-01to2025-11-30" id="Fact000037">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2024-12-01to2025-11-30" id="Fact000038">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2024-12-01to2025-11-30" id="Fact000039">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2024-12-01to2025-11-30" id="Fact000040">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2024-12-01to2025-11-30" id="Fact000041">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2024-12-01to2025-11-30" id="Fact000042">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2024-12-01to2025-11-30" id="Fact000043">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2024-12-01to2025-11-30" id="Fact000044">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag contextRef="From2024-12-01to2025-11-30" id="Fact000045">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="From2024-12-01to2025-11-30" id="Fact000046">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="From2024-12-01to2025-11-30" id="Fact000047">true</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="AsOf2025-05-31"
      decimals="-3"
      id="Fact000048"
      unitRef="USD">73900000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2026-03-06"
      decimals="INF"
      id="Fact000049"
      unitRef="Shares">4153577</dei:EntityCommonStockSharesOutstanding>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="From2024-12-01to2025-11-30" id="Fact000050">We are a special purpose acquisition company with no business operations. Since our Initial Public Offering, our sole business activity has been identifying and evaluating suitable acquisition transaction candidates. Therefore, we do not consider that we face significant cybersecurity risk and have not adopted any cybersecurity risk management program or formal processes for assessing cybersecurity risk. Our board of directors is generally responsible for the oversight of risks from cybersecurity threats, if there are any. In fiscal year 2025, we did not identify any cybersecurity threats that have materially affected or are reasonably likely to materially affect our business strategy, results of operations, or financial condition.</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="From2024-12-01to2025-11-30" id="Fact000051">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="From2024-12-01to2025-11-30" id="Fact000052">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="From2024-12-01to2025-11-30" id="Fact000053">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="From2024-12-01to2025-11-30" id="Fact000054">false</ecd:NonRule10b51ArrTrmntdFlag>
    <dei:AuditorFirmId contextRef="From2024-12-01to2025-11-30" id="Fact000055">206</dei:AuditorFirmId>
    <dei:AuditorName contextRef="From2024-12-01to2025-11-30" id="Fact000056">MaloneBailey, LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="From2024-12-01to2025-11-30" id="Fact000057">Houston, Texas</dei:AuditorLocation>
    <us-gaap:Cash
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000065"
      unitRef="USD">39521</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000066"
      unitRef="USD">264842</us-gaap:Cash>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000068"
      unitRef="USD">11269</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000069"
      unitRef="USD">49229</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000071"
      unitRef="USD">50790</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000072"
      unitRef="USD">314071</us-gaap:AssetsCurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000074"
      unitRef="USD">23827149</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000075"
      unitRef="USD">71829264</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:Assets
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000077"
      unitRef="USD">23877939</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000078"
      unitRef="USD">72143335</us-gaap:Assets>
    <BKHAU:DueToTargetCompany
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000086"
      unitRef="USD">575000</BKHAU:DueToTargetCompany>
    <BKHAU:DueToTargetCompany
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000087"
      unitRef="USD">-0</BKHAU:DueToTargetCompany>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000089"
      unitRef="USD">296410</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000090"
      unitRef="USD">70978</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <BKHAU:AccruedInterestExpenses
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000092"
      unitRef="USD">15454</BKHAU:AccruedInterestExpenses>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000095"
      unitRef="USD">595369</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000096"
      unitRef="USD">-0</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000098"
      unitRef="USD">1482233</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000099"
      unitRef="USD">70978</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredCompensationLiabilityCurrent
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000101"
      unitRef="USD">2415000</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:DeferredCompensationLiabilityCurrent
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000102"
      unitRef="USD">2415000</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000104"
      unitRef="USD">3897233</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000105"
      unitRef="USD">2485978</us-gaap:Liabilities>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2025-11-30_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000113"
      unitRef="USDPShares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2024-11-30_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000115"
      unitRef="USDPShares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2025-11-30_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000117"
      unitRef="Shares">500000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2024-11-30_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000119"
      unitRef="Shares">500000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2025-11-30_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000121"
      unitRef="Shares">6900000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2025-11-30_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000123"
      unitRef="Shares">6900000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2024-11-30_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000125"
      unitRef="Shares">6900000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2024-11-30_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000127"
      unitRef="Shares">6900000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="AsOf2025-11-30_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000129"
      unitRef="USDPShares">11.22</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="AsOf2024-11-30_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000131"
      unitRef="USDPShares">10.41</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000110"
      unitRef="USD">23827149</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000111"
      unitRef="USD">71829264</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-11-30_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000135"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-11-30_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000137"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-11-30_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000138"
      unitRef="Shares">450000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-11-30_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000140"
      unitRef="Shares">450000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-11-30_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000141"
      unitRef="Shares">2029500</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-11-30_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000143"
      unitRef="Shares">2029500</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-11-30_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000145"
      unitRef="Shares">2029500</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-11-30_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000147"
      unitRef="Shares">2029500</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2025-11-30_us-gaap_CommonClassAMember"
      decimals="0"
      id="Fact000149"
      unitRef="USD">203</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-11-30_us-gaap_CommonClassAMember"
      decimals="0"
      id="Fact000151"
      unitRef="USD">203</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000153"
      unitRef="USD">4538</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000156"
      unitRef="USD">-3851184</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000157"
      unitRef="USD">-2172110</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000159"
      unitRef="USD">-3846443</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000160"
      unitRef="USD">-2171907</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000162"
      unitRef="USD">23877939</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000163"
      unitRef="USD">72143335</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000165"
      unitRef="USD">795510</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000166"
      unitRef="USD">492131</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:AdministrativeFeesExpense
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000168"
      unitRef="USD">120000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000169"
      unitRef="USD">83945</us-gaap:AdministrativeFeesExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000171"
      unitRef="USD">-915510</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000172"
      unitRef="USD">-576076</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeOther
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000177"
      unitRef="USD">1798</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000178"
      unitRef="USD">7515</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000180"
      unitRef="USD">2258631</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000181"
      unitRef="USD">2484264</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestExpense
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000183"
      unitRef="USD">15454</us-gaap:InterestExpense>
    <BKHAU:ChangeInFairValueOfDerivativeLiability
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000186"
      unitRef="USD">92</BKHAU:ChangeInFairValueOfDerivativeLiability>
    <us-gaap:OtherIncome
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000189"
      unitRef="USD">2245067</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000190"
      unitRef="USD">2491779</us-gaap:OtherIncome>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000192"
      unitRef="USD">1329557</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000193"
      unitRef="USD">1915703</us-gaap:NetIncomeLoss>
    <BKHAU:BasicAndDilutedWeightedAverageSharesOutstandingClassOrdinarySharesSubjectToPossibleRedemption
      contextRef="From2024-12-01to2025-11-30"
      decimals="INF"
      id="Fact000195"
      unitRef="Shares">5002716</BKHAU:BasicAndDilutedWeightedAverageSharesOutstandingClassOrdinarySharesSubjectToPossibleRedemption>
    <BKHAU:BasicAndDilutedWeightedAverageSharesOutstandingClassOrdinarySharesSubjectToPossibleRedemption
      contextRef="From2023-12-012024-11-30"
      decimals="INF"
      id="Fact000196"
      unitRef="Shares">4769672</BKHAU:BasicAndDilutedWeightedAverageSharesOutstandingClassOrdinarySharesSubjectToPossibleRedemption>
    <BKHAU:BasicAndDilutedNetIncomeLossPerShareClassOrdinarySharesSubjectToPossibleRedemption
      contextRef="From2024-12-01to2025-11-30"
      decimals="INF"
      id="Fact000198"
      unitRef="USDPShares">0.19</BKHAU:BasicAndDilutedNetIncomeLossPerShareClassOrdinarySharesSubjectToPossibleRedemption>
    <BKHAU:BasicAndDilutedNetIncomeLossPerShareClassOrdinarySharesSubjectToPossibleRedemption
      contextRef="From2023-12-012024-11-30"
      decimals="INF"
      id="Fact000199"
      unitRef="USDPShares">0.29</BKHAU:BasicAndDilutedNetIncomeLossPerShareClassOrdinarySharesSubjectToPossibleRedemption>
    <BKHAU:BasicAndDilutedWeightedAverageSharesOutstandingNonredeemableClassOrdinaryShares
      contextRef="From2024-12-01to2025-11-30"
      decimals="INF"
      id="Fact000201"
      unitRef="Shares">2029500</BKHAU:BasicAndDilutedWeightedAverageSharesOutstandingNonredeemableClassOrdinaryShares>
    <BKHAU:BasicAndDilutedWeightedAverageSharesOutstandingNonredeemableClassOrdinaryShares
      contextRef="From2023-12-012024-11-30"
      decimals="INF"
      id="Fact000202"
      unitRef="Shares">1935488</BKHAU:BasicAndDilutedWeightedAverageSharesOutstandingNonredeemableClassOrdinaryShares>
    <BKHAU:BasicAndDilutedNetIncomeLossPerShareNonredeemableClassOrdinaryShares
      contextRef="From2024-12-01to2025-11-30"
      decimals="INF"
      id="Fact000204"
      unitRef="USDPShares">0.19</BKHAU:BasicAndDilutedNetIncomeLossPerShareNonredeemableClassOrdinaryShares>
    <BKHAU:BasicAndDilutedNetIncomeLossPerShareNonredeemableClassOrdinaryShares
      contextRef="From2023-12-012024-11-30"
      decimals="INF"
      id="Fact000205"
      unitRef="USDPShares">0.29</BKHAU:BasicAndDilutedNetIncomeLossPerShareNonredeemableClassOrdinaryShares>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-11-30_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact000212"
      unitRef="Shares">2029500</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-11-30_custom_ClassAOrdinarySharesMember"
      decimals="0"
      id="Fact000207"
      unitRef="USD">203</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-11-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000210"
      unitRef="USD">-2172110</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000211"
      unitRef="USD">-2171907</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <BKHAU:RemeasurementOfCommonStockSubjectToPossibleRedemption
      contextRef="From2024-12-012025-11-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000218"
      unitRef="USD">-3008631</BKHAU:RemeasurementOfCommonStockSubjectToPossibleRedemption>
    <BKHAU:RemeasurementOfCommonStockSubjectToPossibleRedemption
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000219"
      unitRef="USD">-3008631</BKHAU:RemeasurementOfCommonStockSubjectToPossibleRedemption>
    <BKHAU:ReclassificationOfDerivativeLossToApic
      contextRef="From2024-12-012025-11-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000223"
      unitRef="USD">4538</BKHAU:ReclassificationOfDerivativeLossToApic>
    <BKHAU:ReclassificationOfDerivativeLossToApic
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000225"
      unitRef="USD">4538</BKHAU:ReclassificationOfDerivativeLossToApic>
    <us-gaap:ProfitLoss
      contextRef="From2024-12-012025-11-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000230"
      unitRef="USD">1329557</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000231"
      unitRef="USD">1329557</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-11-30_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact000239"
      unitRef="Shares">2029500</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-11-30_custom_ClassAOrdinarySharesMember"
      decimals="0"
      id="Fact000233"
      unitRef="USD">203</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-11-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000235"
      unitRef="USD">4538</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-11-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000236"
      unitRef="USD">-3851184</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000237"
      unitRef="USD">-3846443</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-11-30_custom_ClassBOrdinarySharesMember"
      decimals="INF"
      id="Fact000251"
      unitRef="Shares">1725000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-11-30_custom_ClassBOrdinarySharesMember"
      decimals="0"
      id="Fact000244"
      unitRef="USD">172</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-11-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000245"
      unitRef="USD">24828</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-11-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000246"
      unitRef="USD">-18853</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-11-30"
      decimals="0"
      id="Fact000247"
      unitRef="USD">6147</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <BKHAU:ProceedsFromSaleOfIpoUnitsShares
      contextRef="From2023-12-012024-11-30_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact000259"
      unitRef="Shares">6900000</BKHAU:ProceedsFromSaleOfIpoUnitsShares>
    <BKHAU:ProceedsFromSaleOfIpoUnits
      contextRef="From2023-12-012024-11-30_custom_ClassAOrdinarySharesMember"
      decimals="0"
      id="Fact000253"
      unitRef="USD">690</BKHAU:ProceedsFromSaleOfIpoUnits>
    <BKHAU:ProceedsFromSaleOfIpoUnits
      contextRef="From2023-12-012024-11-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000255"
      unitRef="USD">68999310</BKHAU:ProceedsFromSaleOfIpoUnits>
    <BKHAU:ProceedsFromSaleOfIpoUnits
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000257"
      unitRef="USD">69000000</BKHAU:ProceedsFromSaleOfIpoUnits>
    <BKHAU:ProceedsFromSaleOfPrivatePlacementUnitsShares
      contextRef="From2023-12-012024-11-30_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact000267"
      unitRef="Shares">235500</BKHAU:ProceedsFromSaleOfPrivatePlacementUnitsShares>
    <BKHAU:ProceedsFromSaleOfPrivatePlacementUnits
      contextRef="From2023-12-012024-11-30_custom_ClassAOrdinarySharesMember"
      decimals="0"
      id="Fact000261"
      unitRef="USD">24</BKHAU:ProceedsFromSaleOfPrivatePlacementUnits>
    <BKHAU:ProceedsFromSaleOfPrivatePlacementUnits
      contextRef="From2023-12-012024-11-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000263"
      unitRef="USD">2354976</BKHAU:ProceedsFromSaleOfPrivatePlacementUnits>
    <BKHAU:ProceedsFromSaleOfPrivatePlacementUnits
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000265"
      unitRef="USD">2355000</BKHAU:ProceedsFromSaleOfPrivatePlacementUnits>
    <BKHAU:IssuanceOfRepresentativeSharesShares
      contextRef="From2023-12-012024-11-30_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact000275"
      unitRef="Shares">69000</BKHAU:IssuanceOfRepresentativeSharesShares>
    <BKHAU:IssuanceOfRepresentativeShares
      contextRef="From2023-12-012024-11-30_custom_ClassAOrdinarySharesMember"
      decimals="0"
      id="Fact000269"
      unitRef="USD">7</BKHAU:IssuanceOfRepresentativeShares>
    <BKHAU:IssuanceOfRepresentativeShares
      contextRef="From2023-12-012024-11-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000271"
      unitRef="USD">689993</BKHAU:IssuanceOfRepresentativeShares>
    <BKHAU:IssuanceOfRepresentativeShares
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000273"
      unitRef="USD">690000</BKHAU:IssuanceOfRepresentativeShares>
    <BKHAU:CommonStockSubjectToPossibleRedemptionShares
      contextRef="From2023-12-012024-11-30_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact000283"
      unitRef="Shares">-6900000</BKHAU:CommonStockSubjectToPossibleRedemptionShares>
    <BKHAU:CommonStockSubjectToPossibleRedemption
      contextRef="From2023-12-012024-11-30_custom_ClassAOrdinarySharesMember"
      decimals="0"
      id="Fact000277"
      unitRef="USD">-690</BKHAU:CommonStockSubjectToPossibleRedemption>
    <BKHAU:CommonStockSubjectToPossibleRedemption
      contextRef="From2023-12-012024-11-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000279"
      unitRef="USD">-69344310</BKHAU:CommonStockSubjectToPossibleRedemption>
    <BKHAU:CommonStockSubjectToPossibleRedemption
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000281"
      unitRef="USD">-69345000</BKHAU:CommonStockSubjectToPossibleRedemption>
    <BKHAU:ConversionOfClassBToClassOrdinarySharesShares
      contextRef="From2023-12-012024-11-30_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact000291"
      unitRef="Shares">1725000</BKHAU:ConversionOfClassBToClassOrdinarySharesShares>
    <BKHAU:ConversionOfClassBToClassOrdinaryShares
      contextRef="From2023-12-012024-11-30_custom_ClassAOrdinarySharesMember"
      decimals="0"
      id="Fact000285"
      unitRef="USD">172</BKHAU:ConversionOfClassBToClassOrdinaryShares>
    <BKHAU:ConversionOfClassBToClassOrdinarySharesShares
      contextRef="From2023-12-012024-11-30_custom_ClassBOrdinarySharesMember"
      decimals="INF"
      id="Fact000293"
      unitRef="Shares">-1725000</BKHAU:ConversionOfClassBToClassOrdinarySharesShares>
    <BKHAU:ConversionOfClassBToClassOrdinaryShares
      contextRef="From2023-12-012024-11-30_custom_ClassBOrdinarySharesMember"
      decimals="0"
      id="Fact000286"
      unitRef="USD">-172</BKHAU:ConversionOfClassBToClassOrdinaryShares>
    <BKHAU:UnderwriterCommissions
      contextRef="From2023-12-012024-11-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000297"
      unitRef="USD">-3795000</BKHAU:UnderwriterCommissions>
    <BKHAU:UnderwriterCommissions
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000299"
      unitRef="USD">-3795000</BKHAU:UnderwriterCommissions>
    <BKHAU:OfferingCosts
      contextRef="From2023-12-012024-11-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000303"
      unitRef="USD">-679743</BKHAU:OfferingCosts>
    <BKHAU:OfferingCosts
      contextRef="From2023-12-012024-11-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000304"
      unitRef="USD">165250</BKHAU:OfferingCosts>
    <BKHAU:OfferingCosts
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000305"
      unitRef="USD">-514493</BKHAU:OfferingCosts>
    <BKHAU:AccretionOfAdditionalPaidInCapitalToAccumulatedDeficit
      contextRef="From2023-12-012024-11-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000309"
      unitRef="USD">1749946</BKHAU:AccretionOfAdditionalPaidInCapitalToAccumulatedDeficit>
    <BKHAU:AccretionOfAdditionalPaidInCapitalToAccumulatedDeficit
      contextRef="From2023-12-012024-11-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000310"
      unitRef="USD">-1749946</BKHAU:AccretionOfAdditionalPaidInCapitalToAccumulatedDeficit>
    <BKHAU:RemeasurementOfCommonStockSubjectToPossibleRedemption
      contextRef="From2023-12-012024-11-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000316"
      unitRef="USD">-2484264</BKHAU:RemeasurementOfCommonStockSubjectToPossibleRedemption>
    <BKHAU:RemeasurementOfCommonStockSubjectToPossibleRedemption
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000317"
      unitRef="USD">-2484264</BKHAU:RemeasurementOfCommonStockSubjectToPossibleRedemption>
    <us-gaap:ProfitLoss
      contextRef="From2023-12-012024-11-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000322"
      unitRef="USD">1915703</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000323"
      unitRef="USD">1915703</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-11-30_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact000331"
      unitRef="Shares">2029500</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-11-30_custom_ClassAOrdinarySharesMember"
      decimals="0"
      id="Fact000325"
      unitRef="USD">203</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-11-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000328"
      unitRef="USD">-2172110</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000329"
      unitRef="USD">-2171907</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000338"
      unitRef="USD">1329557</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000339"
      unitRef="USD">1915703</us-gaap:NetIncomeLoss>
    <BKHAU:InterestIncomeExpenseNets
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000344"
      unitRef="USD">2258631</BKHAU:InterestIncomeExpenseNets>
    <BKHAU:InterestIncomeExpenseNets
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000345"
      unitRef="USD">2484264</BKHAU:InterestIncomeExpenseNets>
    <BKHAU:ChangeInFairValueOfDerivativeLiabilities
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000347"
      unitRef="USD">92</BKHAU:ChangeInFairValueOfDerivativeLiabilities>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000353"
      unitRef="USD">-37960</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000354"
      unitRef="USD">49229</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000356"
      unitRef="USD">240885</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000357"
      unitRef="USD">64125</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000359"
      unitRef="USD">-650321</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000360"
      unitRef="USD">-553665</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsForPurchaseOfOtherAssets1
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000366"
      unitRef="USD">69345000</us-gaap:PaymentsForPurchaseOfOtherAssets1>
    <BKHAU:CashDepositedInTrustAccount
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000368"
      unitRef="USD">750000</BKHAU:CashDepositedInTrustAccount>
    <BKHAU:CashWithdrawanFromTrustToPayRedeemedPublicShareholders
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000371"
      unitRef="USD">51010745</BKHAU:CashWithdrawanFromTrustToPayRedeemedPublicShareholders>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000374"
      unitRef="USD">50260745</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000375"
      unitRef="USD">-69345000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <BKHAU:ProceedsFromIssuanceOfPromissoryNoteToRelatedParty
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000380"
      unitRef="USD">600000</BKHAU:ProceedsFromIssuanceOfPromissoryNoteToRelatedParty>
    <BKHAU:ProceedsFromDueToTargetCompany
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000383"
      unitRef="USD">575000</BKHAU:ProceedsFromDueToTargetCompany>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000387"
      unitRef="USD">69000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000390"
      unitRef="USD">2355000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000393"
      unitRef="USD">690000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000396"
      unitRef="USD">30900</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:RepaymentsOfOtherDebt
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000399"
      unitRef="USD">690000</us-gaap:RepaymentsOfOtherDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000402"
      unitRef="USD">250000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000405"
      unitRef="USD">1097493</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfOrdinaryDividends
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000407"
      unitRef="USD">51010745</us-gaap:PaymentsOfOrdinaryDividends>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000410"
      unitRef="USD">-49835745</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000411"
      unitRef="USD">70038407</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000413"
      unitRef="USD">-225321</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000414"
      unitRef="USD">139742</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000416"
      unitRef="USD">264842</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-11-30"
      decimals="0"
      id="Fact000417"
      unitRef="USD">125100</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000419"
      unitRef="USD">39521</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000420"
      unitRef="USD">264842</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <BKHAU:IssuanceOfConvertibleNoteRecognitionOfDerivativeLiability
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000425"
      unitRef="USD">4630</BKHAU:IssuanceOfConvertibleNoteRecognitionOfDerivativeLiability>
    <BKHAU:ReclassificationOfDerivativeLiabilityToApic
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000428"
      unitRef="USD">4538</BKHAU:ReclassificationOfDerivativeLiabilityToApic>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000432"
      unitRef="USD">172</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <BKHAU:InitialClassificationOfCommonStockSubjectToPossibleRedemption
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000435"
      unitRef="USD">69345000</BKHAU:InitialClassificationOfCommonStockSubjectToPossibleRedemption>
    <BKHAU:AccretionsOfAdditionalPaidInCapitalToAccumulatedDeficit
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000438"
      unitRef="USD">1749946</BKHAU:AccretionsOfAdditionalPaidInCapitalToAccumulatedDeficit>
    <BKHAU:ChangeInValueOfClassCommonStockSubjectToPossibleRedemption
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000440"
      unitRef="USD">3008631</BKHAU:ChangeInValueOfClassCommonStockSubjectToPossibleRedemption>
    <BKHAU:ChangeInValueOfClassCommonStockSubjectToPossibleRedemption
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000441"
      unitRef="USD">2484264</BKHAU:ChangeInValueOfClassCommonStockSubjectToPossibleRedemption>
    <BKHAU:DeferredUnderwritingFeePayable
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000444"
      unitRef="USD">2415000</BKHAU:DeferredUnderwritingFeePayable>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2024-12-01to2025-11-30" id="Fact000446">&lt;p id="xdx_808_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_z61dfIXu4kXj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 1 &#x2014; &lt;span id="xdx_820_ziO2PNn3QNfe"&gt;Description of Organization and Business Operations&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Black Hawk Acquisition Corporation (the &#x201c;Company&#x201d;) is a blank check company incorporated under the laws of the Cayman Islands with limited liability on September&#160;28, 2023. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (&#x201c;Business Combination&#x201d;). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of November 30, 2025, the Company had not commenced any operations. All activities through November 30, 2025 are related to the Company&#x2019;s formation and the initial public offering (&#x201c;IPO&#x201d; as defined below), and subsequent to the IPO, identifying a target company for an initial business combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the IPO. The Company has selected November&#160;30 as its fiscal year end.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s sponsor is Black Hawk Management LLC (the &#x201c;Sponsor&#x201d;), a Delaware limited liability company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The registration statement for the Company&#x2019;s IPO became effective on March&#160;20, 2024. On March&#160;22, 2024, the Company consummated the IPO of &lt;span id="xdx_90A_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240301__20240322__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_znKVnUn50gwl" title="Sale of units in public offering"&gt;6,900,000&lt;/span&gt; units (which does not include the exercise of the over-allotment option by the underwriters in the IPO) at an offering price of $&lt;span id="xdx_904_eus-gaap--SaleOfStockPricePerShare_iI_c20240322__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zPpqSJ0pGTif" title="Sale of units per share"&gt;10.00&lt;/span&gt; per unit (the &#x201c;Public Units&#x2019;), generating gross proceeds of $&lt;span id="xdx_90D_ecustom--ProceedsFromSaleOfIpoUnits_pp0p0_c20240301__20240322__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zURWLmrn83l9" title="Proceeds from sale of IPO Units"&gt;69,000,000&lt;/span&gt;. Simultaneously with the IPO, the Company sold to its Sponsor &lt;span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240301__20240322__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zdU7TbNs09Ge" title="Sale of units in public offering"&gt;235,500&lt;/span&gt; units at $&lt;span id="xdx_907_eus-gaap--SaleOfStockPricePerShare_iI_c20240322__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zAu4tykKZlj1" title="Sale of units per share"&gt;10.00&lt;/span&gt; per unit (the &#x201c;Private Units&#x201d;) in a private placement generating total gross proceeds of $&lt;span id="xdx_90E_ecustom--ProceedsFromSaleOfPrivatePlacementUnitsShares_c20240301__20240322__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z5nybQ9OMQU8" title="Proceeds from sale of private placements"&gt;2,355,000&lt;/span&gt;, which is described in Note 4.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Transaction costs amounted to $&lt;span id="xdx_903_ecustom--TransactionCosts_pp0p0_c20241201__20251130_zFPWxtv4muj6" title="Transaction costs"&gt;4,309,493&lt;/span&gt;, consisted of $&lt;span id="xdx_908_ecustom--CashUnderwriting_pp0p0_c20241201__20251130_zVAGrZFScAx" title="Cash underwriting"&gt;690,000 &lt;/span&gt;cash underwriting, $&lt;span id="xdx_908_eus-gaap--OtherUnderwritingExpense_pp0p0_c20241201__20251130_zvvC11KlvS7i" title="Deferred underwriting fees"&gt;2,415,000 &lt;/span&gt;deferred underwriting fees (payable only upon completion of a Business Combination), $&lt;span id="xdx_906_ecustom--IssuanceOfRepresentativeShare_pp0p0_c20241201__20251130_zkMWa1oIh5Ed" title="Issuance of representative shares"&gt;690,000 &lt;/span&gt; issuance of representative shares and $&lt;span id="xdx_908_eus-gaap--DeferredOfferingCosts_iI_pp0p0_c20251130_zBZp3UsQJ214" title="Other offering costs"&gt;514,493 &lt;/span&gt;other offering costs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Upon the closing of the IPO and the private placement on March&#160;22, 2024, a total of $&lt;span id="xdx_901_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pp0p0_c20240301__20240322_zBn6eO79L8p1" title="Proceeds from sale of public units"&gt;69,345,000&lt;/span&gt; was placed in a trust account (the &#x201c;Trust Account&#x201d;) maintained by Continental Stock Transfer &amp;amp; Trust Company as a trustee and will be invested only in U.S. government treasury bills with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule&#160;2a-7 under the Investment Company Act of 1940, as amended (the &#x201c;Investment Company Act&#x201d;), and that invest only in direct U.S. government treasury obligations. These funds will not be released until the earlier of the completion of the initial Business Combination and the liquidation due to the Company&#x2019;s failure to complete a Business Combination within the applicable period of time. The proceeds deposited in the Trust Account could become subject to the claims of the Company&#x2019;s creditors, if any, which could have priority over the claims of the Company&#x2019;s public shareholders. In addition, interest income earned on the funds in the Trust Account may be released to the Company to pay its income or other tax obligations. With these exceptions, expenses incurred by the Company may be paid prior to a business combination only from the net proceeds of the IPO and private placement not held in the Trust Account.&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Pursuant to Nasdaq listing rules, the Company&#x2019;s initial Business Combination must occur with one or more target businesses having an aggregate fair market value equal to at least 80% of the value of the funds in the Trust account (excluding any deferred underwriting discounts and commissions and taxes payable on the income earned on the Trust Account), which the Company refers to as the &lt;span id="xdx_90D_ecustom--PercentageOfAssetHeldInTrustAccount_dp_c20241201__20251130_zzuRhKBZ9CYg" title="Percentage of asset held in trust account"&gt;80&lt;/span&gt;% test, at the time of the execution of a definitive agreement for its initial Business Combination, although the Company may structure a Business Combination with one or more target businesses whose fair market value significantly exceeds 80% of the trust account balance. If the Company is no longer listed on Nasdaq, it will not be required to satisfy the 80% test. The Company will only complete a Business Combination if the post-transaction company owns or acquires &lt;span id="xdx_907_ecustom--BusinessCombinationPercentageOfVotingSecurities_iI_dp_c20251130_zZtVId2kDEvh" title="Business combination, percentage of voting securities"&gt;50&lt;/span&gt;% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company will provide its holders of the outstanding Public Shares (the &#x201c;Public Shareholders&#x201d;) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $&lt;span id="xdx_90B_eus-gaap--SharePrice_iI_c20251130__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zoYiEdYaoIgd" title="Share price"&gt;10.00&lt;/span&gt; per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its franchise and income tax obligations). The Public Shares subject to redemption will be recorded at a redemption value and classified as temporary equity upon the completion of the Proposed Offering in accordance with the Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 480 &#x201c;Distinguishing Liabilities from Equity.&#x201d;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company will proceed with a Business Combination if the Company has net tangible assets of at least $&lt;span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20251130_z7z7un2ONoea" title="Net tangible assets"&gt;5,000,001&lt;/span&gt; upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its amended and restated memorandum and articles of association, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each public shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the Company&#x2019;s Sponsor and any of the Company&#x2019;s officers or directors that may hold Founder Shares (as defined in Note 5) (the &#x201c;Initial Shareholders&#x201d;) and the underwriters have agreed (a) to vote their Founder Shares, Private Shares (as defined in Note 4), Shares issued as underwriting commissions (see Note 6) and any Public Shares purchased during or after the Proposed Public Offering in favor of approving a Business Combination and (b) not to convert any shares (including the Founder Shares) in connection with a shareholder vote to approve, or sell the shares to the Company in any tender offer in connection with, a proposed Business Combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;If the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the amended and restated memorandum and articles of association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a &#x201c;group&#x201d; (as defined under Section&#160;13 of the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Initial Shareholders have agreed (a) to waive their redemption rights with respect to the Founder Shares, Private Shares, and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose, or vote in favor of, an amendment to the Amended and Restated Certificate of Incorporation that would affect the substance or timing of the Company&#x2019;s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company will have 15 months (or up to 18 months or up to 21 months if it extends such period) from the closing of the IPO to consummate a Business Combination (the &#x201c;Combination Period&#x201d;). If the Company anticipates that that it may not be able to consummate initial business combination within 15 months, the Company&#x2019;s insiders or their affiliates may, but are not obligated to, extend the period of time to consummate a business combination two times by an additional three months each time (for a total of 21 months to complete a business combination) (the &#x201c;Combination Period&#x201d;). In order to extend the time available for the Company to consummate a Business Combination, the Sponsor or its affiliate or designees must deposit into the Trust Account $&lt;span id="xdx_908_eus-gaap--Deposits_pp0p0_c20251130_zKpZdoypyyH"&gt;690,000 &lt;/span&gt;($&lt;span id="xdx_90B_eus-gaap--SharePrice_c20251130__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zyOLWlWZTmK4"&gt;0.10 &lt;/span&gt;per Public Share) or an aggregate of $&lt;span id="xdx_906_ecustom--AggregateAmount_pp0p0_c20241201__20251130__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z7a2QxLxw1t9" title="Aggregate amount"&gt;1,380,000&lt;/span&gt;, on or prior to the date of the applicable deadline.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account including interest (which interest shall be net of taxes payable and less up to $&lt;span id="xdx_906_eus-gaap--InterestPayableCurrent_iI_pp0p0_c20251130_zHHMAf4s3O2d" title="Interest payable"&gt;100,000&lt;/span&gt; of interest to pay liquidation and dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders&#x2019; rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company&#x2019;s remaining shareholders and the Company&#x2019;s board of directors, dissolve and liquidate, subject in each case to the Company&#x2019;s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Sponsor and the other Initial Shareholders have agreed to waive their liquidation rights with respect to the Founder Shares, and Private Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or the other Initial Shareholders acquires Public Shares in or after the IPO, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than $10.05.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below $10.05 per Public Share, except as to any claims by a third party who executed a valid and enforceable agreement with the Company waiving any right, title, interest or claim of any kind they may have in or to any monies held in the Trust Account and except as to any claims under the Company&#x2019;s indemnity of the underwriters of Proposed Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On March 10, 2025, the Company entered into a non-binding letter of intent (the &#x201c;LOI&#x201d;) with a business combination target, Vesicor Therapeutics, Inc. (&#x201c;Vesicor&#x201d;), regarding a potential business combination (the &#x201c;Transaction&#x201d;). Vesicor is a California-based early development stage biotechnology corporation focused on the development of p53-based cancer therapeutics delivered via precision-engineered microvesicles.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On March 15, 2025, the Company and Vesicor executed a subsequent letter of intent with an exclusivity period extending until the last day of April 2025 (the &#x201c;Exclusive LOI&#x201d;). Pursuant to the LOI, Vesicor deposited two non-refundable deposits totaling $&lt;span id="xdx_900_eus-gaap--Deposits_iI_c20250315_zdRXfAC9umza" title="Deposits"&gt;250,000&lt;/span&gt; into the Company&#x2019;s operating account to cover the costs related to Proposed Transaction.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 22, 2025, BH Merger Sub, Inc. (&#x201c;Merger Sub&#x201d;), a wholly owned subsidiary of the Company and a Delaware corporation, was formed to be the surviving company after the merger in connection with a contemplated business combination. It has no principal operations or revenue producing activities.&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;b&gt;Business Combination Agreement&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 26, 2025, the Company entered into a Business Combination Agreement (the &#x201c;Business Combination Agreement&#x201d;) by and among Vesicor and Merger Sub, of which Vesicor shall reincorporate into the State of Delaware so as to migrate to and domesticate as a Delaware corporation on the day that is one (1) Business Day prior to the Closing Date. The Business Combination Agreement provides, among other things, that on the terms and subject to the conditions set forth therein, (i) the Company will de-register in the Cayman Islands and transfer by way of continuation out of the Cayman Islands and into the State of Delaware so as to migrate to and domesticate as a Delaware corporation (the &#x201c;&lt;span style="text-decoration: underline"&gt;Domestication&lt;/span&gt;&#x201d;), and (ii) following the Domestication, Merger Sub will merge with Vesicor, resulting in Vesicor being the wholly owned subsidiary of the Company, who will continue to be the listed company on the Nasdaq Stock Market and change its name to Vesicor. At the effective time of the Proposed Transaction, Vesicor&#x2019;s shareholders and management will receive the right to receive a number of shares of Black Hawk&#x2019;s&#160;common stock&#160;equal to the consideration ratio as further specified in the Business Combination Agreement. The shares held by certain Vesicor&#x2019;s shareholders will be subject to lock-up agreements for a period of six (6) months following the closing of the Proposed Transaction, subject to certain exceptions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Transaction values Vesicor at a pre-money equity value of $&lt;span id="xdx_904_ecustom--TransactionValue_pn3n3_dm_c20241201__20251130_zszJEeZGmg6e" title="Transaction value"&gt;70&lt;/span&gt; million. Existing Vesicor shareholders and management will not receive any cash proceeds as part of the transaction and will roll over 100% of their equity into the combined company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Transaction, which has been approved unanimously by the boards of directors of both Black Hawk and Vesicor, is subject to regulatory approvals, the approvals by the shareholders of Black Hawk and Vesicor, respectively, and the satisfaction of certain other customary closing conditions including the approval by Nasdaq of the listing application of the combined company. The completion of the Business Combination remains subject to the satisfaction or waiver of customary closing conditions, including the
effectiveness of the Registration Statement on Form S-4 and Nasdaq listing approval. There can be no assurance as to the timing of the
completion of the Business Combination or that it will be completed at all.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;b&gt;2025 Extraordina&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ry General Meeting&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company filed its definitive proxy statement on June 10, 2025, announcing its Extraordinary General Meeting would be held on June 20, 2025 to vote on three proposals: (i) a proposal by special resolution to amend the Second Amended and Restated Memorandum and Articles of Association to allow the Company to extend the deadline for the Combination Period by up to eighteen (18) one-month extensions, from June 22, 2025 (the &#x201c;Termination Date&#x201d;) to December 22, 2026, for a maximum of 36 months from the date of the Company&#x2019;s initial public offering; (ii) a related proposal by special resolution to amend the Trust Agreement, dated March 20, 2024, by and between Black Hawk and Continental Stock Transfer &amp;amp; Trust Company, to allow for such one-month extensions, with each extension conditioned upon the deposit into the Trust Account of $0.03 per remaining public share (after redemptions) for each month extended;, and (iii) a proposal, by ordinary resolution, to adjourn the Extraordinary General Meeting, to a later date or dates, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Extraordinary General Meeting, there are not sufficient votes to approve the proposals.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On June 20, 2025, the Company held its Extraordinary General Meeting which, without conducting any business was adjourned. The Extraordinary General Meeting was adjourned again on June 23, 2025; June 27, 2025; July 1, 2025; and July 3, 2025 in order to solicit additional votes on the matters listed in the notice of Extraordinary General Meeting and the proxy statement, particularly the Trust Amendment Proposal (further described below).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Also on June 20, 2025, the Company filed a supplemental proxy statement revising the language of the Trust Amendment Proposal. Specifically, the original language referencing deposits of &#x201c;up to $&lt;span id="xdx_900_eus-gaap--Deposits_iI_c20250630_zQ3JYTpCMOj2" title="Deposits"&gt;55,000&lt;/span&gt; per one-month extension&#x201d; was removed and replaced with a new structure. As revised, the proposal allows Black Hawk to extend the Termination Date up to eighteen (18) times, each for an additional one (1) month, from the current Termination Date to December 22, 2026, by depositing into the Trust Account $0.033 per remaining public share (after redemptions) for each monthly extension, in accordance with the Company&#x2019;s Trust Agreement, dated March 20, 2024, with Continental Stock Transfer &amp;amp; Trust Company, as trustee.&lt;/span&gt;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On July 7, 2025, the Company filed a supplemental proxy statement further amending the Extension Proposal. The amendment revised the proposed termination date from June 22, 2025 to December 22, 2026, and modified the terms of the Trust Agreement Amendment Proposal. Under the revised terms, the Company may extend the deadline to consummate a business combination by up to eighteen (18) one-month periods, with each extension conditioned upon a deposit of $&lt;span id="xdx_909_eus-gaap--Deposits_iI_c20250707_zuXvtdjIDcI5" title="Deposits"&gt;150,000&lt;/span&gt; per month into the Trust Account, in accordance with the Investment Management Trust Agreement, dated March 20, 2024, between the Company and Continental Stock Transfer &amp;amp; Trust Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company held its Extraordinary General Meeting on July 8, 2025, at which shareholders approved the Extension Proposal and related amendments to Black Hawk&#x2019;s governing documents and Trust Agreement. As a result, Black Hawk now has the ability to extend the business combination deadline monthly through December 22, 2026, subject to making the required $&lt;span id="xdx_90D_eus-gaap--Deposits_iI_c20250708_zIzXm0KTU7Cj" title="Deposits"&gt;150,000&lt;/span&gt; monthly deposits into the Trust Account.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In connection with the Extraordinary General Meeting, holders of &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20241201__20251130__us-gaap--StatementEquityComponentsAxis__custom--OrdinarySharesMember_zVioXSX83H1d" title="Shares exercised"&gt;4,775,923&lt;/span&gt; public ordinary shares exercised their redemption rights, resulting in a total payment of approximately $&lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_dm_c20241201__20251130__us-gaap--StatementEquityComponentsAxis__custom--OrdinarySharesMember_zUdPGL8GsNn3" title="Shares exercised, value"&gt;51.0&lt;/span&gt; million (at approximately $10.68 per share) from the Trust Account. Following the redemptions, approximately $&lt;span id="xdx_906_eus-gaap--Deposits_iI_pn3n3_dm_c20251130__us-gaap--StatementEquityComponentsAxis__custom--OrdinarySharesMember_zAZhDP7tDtcj" title="Deposits"&gt;22.7&lt;/span&gt; million remains in the Trust Account, and &lt;span id="xdx_908_ecustom--ClassOdinarySharesSubjectToPossibleRedemptionSharesIssued_iI_c20251130__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zk45AT3hfA3j" title="Class A Odinary shares subject to possible redemption, shares issued"&gt;&lt;span id="xdx_90A_ecustom--ClassOdinarySharesSubjectToPossibleRedemptionSharesOutstanding_iI_c20251130__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_znInOBUcyQq3" title="Class A Odinary shares subject to possible redemption, shares outstanding"&gt;2,124,077&lt;/span&gt;&lt;/span&gt; public ordinary shares remain issued and outstanding.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif; text-decoration: underline"&gt;&lt;b&gt;Extension Payment&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the Extension, the Sponsor agreed to make Extension Payment following the approval and implementation of the
Extension. Beginning on June 22, 2025 until December 22, 2026, Black Hawk may elect to extend the date by which Black Hawk has to
consummate a business combination month-by-month each time for a total of up to eighteen times by depositing $&lt;span id="xdx_904_eus-gaap--Deposits_iI_c20250622_zSEBg4uDggl4" title="Deposits"&gt;150,000&lt;/span&gt;
for each such one-month extension into Black Hawk&#x2019;s Trust Account. On July 15, 2025, Black Hawk exercised its first extension
by depositing $&lt;span id="xdx_90E_eus-gaap--Deposits_iI_c20250715_zGRimnJXOV2l" title="Deposits"&gt;150,000&lt;/span&gt;
into the Trust Accou&lt;/span&gt;nt to extend the deadline to complete the Business Combination from June 22, 2025 to July 22, 2025. The
Company has exercised monthly extensions beginning June 22, 2025 by depositing $150,000 into the Trust Account for each applicable
extension period. As discussed above, certain extension payments due in December 2025 and January 2026 were funded after their
respective due dates. As of the issuance date of these financial statements, the Company is current with respect to its extension
payments. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Going Concern Consideration&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of November&#160;30, 2025, the Company had $&lt;span id="xdx_902_eus-gaap--CashEquivalentsAtCarryingValue_pp0p0_c20251130_zHBhdGuQANuh" title="Cash"&gt;39,521&lt;/span&gt; in cash and working capital deficit of $&lt;span id="xdx_90E_ecustom--WorkingCapitalDeficit_pp0p0_c20251130_zwCF8TX1DOVl" title="Working capital deficit"&gt;1,431,443&lt;/span&gt;. The Company&#x2019;s liquidity needs prior to the consummation of the IPO had been satisfied through a payment from the Sponsor of $&lt;span id="xdx_907_ecustom--PaymentsFromSponser_pp0p0_c20251130_zRZ5i6pEOAd8" title="Payments from the sponser"&gt;25,000&lt;/span&gt; for the Founder Shares and the loan under an unsecured promissory note from the Sponsor of $&lt;span id="xdx_901_eus-gaap--UnsecuredDebt_iI_pp0p0_c20251130_z0Jc3H0u1nv9" title="Unsecured promissory note from sponsor"&gt;250,000&lt;/span&gt; (see Note 5).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has incurred and expects to continue to incur significant professional costs to remain as a publicly traded company and to incur significant transaction costs in pursuit of the consummation of a Business Combination. In connection with the Company&#x2019;s assessment of going concern considerations in accordance with Financial Accounting Standard Board&#x2019;s Accounting Standards Update (&#x201c;ASU&#x201d;) 2014-15, &#x201c;Disclosures of Uncertainties about an Entity&#x2019;s Ability to Continue as a Going Concern,&#x201d; management has determined that these conditions raise substantial doubt about the Company&#x2019;s ability to continue as a going concern. In addition, if the Company is unable to complete a Business Combination within the Combination Period, the Company&#x2019;s board of directors would proceed to commence voluntary liquidation and thereby a formal dissolution of the Company. There is no assurance that the Company&#x2019;s plans to consummate a Business Combination will be successful within the Combination Period. As a result, management has determined that such additional condition also raises substantial doubt about the Company&#x2019;s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Risks and Uncertainties&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Various social and political circumstances in the U.S. and around the world (including rising trade tensions between the U.S. and China, and other uncertainties regarding actual and potential shifts in the U.S. and foreign, trade, economic and other policies with other countries), may contribute to increased market volatility and economic uncertainties or deterioration in the U.S. and worldwide.&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As a result of these circumstances and the ongoing Russia/Ukraine, Hamas/Israel conflicts and/or other future global conflicts, the Company&#x2019;s ability to consummate a Business Combination, or the operations of a target business with which the Company ultimately consummates a Business Combination, may be materially and adversely affected. In addition, the Company&#x2019;s ability to consummate a transaction may be dependent on the ability to raise equity and debt financing which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity in third-party financing being unavailable on terms acceptable to the Company or at all. The impact of this action and related sanctions on the world economy and the specific impact on the Company&#x2019;s financial position, results of operations and/or ability to consummate a Business Combination are not yet determinable. The unaudited financial statements do not include any adjustments that might result from the outcome of these risks and uncertainties.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-03-012024-03-22_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000448"
      unitRef="Shares">6900000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2024-03-22_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000450"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <BKHAU:ProceedsFromSaleOfIpoUnits
      contextRef="From2024-03-012024-03-22_us-gaap_IPOMember"
      decimals="0"
      id="Fact000452"
      unitRef="USD">69000000</BKHAU:ProceedsFromSaleOfIpoUnits>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-03-012024-03-22_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000454"
      unitRef="Shares">235500</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2024-03-22_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000456"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <BKHAU:ProceedsFromSaleOfPrivatePlacementUnitsShares
      contextRef="From2024-03-012024-03-22_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000458"
      unitRef="Shares">2355000</BKHAU:ProceedsFromSaleOfPrivatePlacementUnitsShares>
    <BKHAU:TransactionCosts
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000460"
      unitRef="USD">4309493</BKHAU:TransactionCosts>
    <BKHAU:CashUnderwriting
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000462"
      unitRef="USD">690000</BKHAU:CashUnderwriting>
    <us-gaap:OtherUnderwritingExpense
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000464"
      unitRef="USD">2415000</us-gaap:OtherUnderwritingExpense>
    <BKHAU:IssuanceOfRepresentativeShare
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000466"
      unitRef="USD">690000</BKHAU:IssuanceOfRepresentativeShare>
    <us-gaap:DeferredOfferingCosts
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000468"
      unitRef="USD">514493</us-gaap:DeferredOfferingCosts>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2024-03-012024-03-22"
      decimals="0"
      id="Fact000470"
      unitRef="USD">69345000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <BKHAU:PercentageOfAssetHeldInTrustAccount
      contextRef="From2024-12-01to2025-11-30"
      decimals="INF"
      id="Fact000474"
      unitRef="Pure">0.80</BKHAU:PercentageOfAssetHeldInTrustAccount>
    <BKHAU:BusinessCombinationPercentageOfVotingSecurities
      contextRef="AsOf2025-11-30"
      decimals="INF"
      id="Fact000476"
      unitRef="Pure">0.50</BKHAU:BusinessCombinationPercentageOfVotingSecurities>
    <us-gaap:SharePrice
      contextRef="AsOf2025-11-30_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000478"
      unitRef="USDPShares">10.00</us-gaap:SharePrice>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000480"
      unitRef="USD">5000001</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:Deposits
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000483"
      unitRef="USD">690000</us-gaap:Deposits>
    <us-gaap:SharePrice
      contextRef="AsOf2025-11-30_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000484"
      unitRef="USDPShares">0.10</us-gaap:SharePrice>
    <BKHAU:AggregateAmount
      contextRef="From2024-12-012025-11-30_us-gaap_OverAllotmentOptionMember"
      decimals="0"
      id="Fact000486"
      unitRef="USD">1380000</BKHAU:AggregateAmount>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000488"
      unitRef="USD">100000</us-gaap:InterestPayableCurrent>
    <us-gaap:Deposits
      contextRef="AsOf2025-03-15"
      decimals="0"
      id="Fact000490"
      unitRef="USD">250000</us-gaap:Deposits>
    <BKHAU:TransactionValue
      contextRef="From2024-12-01to2025-11-30"
      decimals="-3"
      id="Fact000494"
      unitRef="USD">70000000</BKHAU:TransactionValue>
    <us-gaap:Deposits
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000496"
      unitRef="USD">55000</us-gaap:Deposits>
    <us-gaap:Deposits
      contextRef="AsOf2025-07-07"
      decimals="0"
      id="Fact000500"
      unitRef="USD">150000</us-gaap:Deposits>
    <us-gaap:Deposits
      contextRef="AsOf2025-07-08"
      decimals="0"
      id="Fact000502"
      unitRef="USD">150000</us-gaap:Deposits>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2024-12-012025-11-30_custom_OrdinarySharesMember"
      decimals="INF"
      id="Fact000504"
      unitRef="Shares">4775923</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2024-12-012025-11-30_custom_OrdinarySharesMember"
      decimals="-3"
      id="Fact000506"
      unitRef="USD">51000000.0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:Deposits
      contextRef="AsOf2025-11-30_custom_OrdinarySharesMember"
      decimals="-3"
      id="Fact000508"
      unitRef="USD">22700000</us-gaap:Deposits>
    <BKHAU:ClassOdinarySharesSubjectToPossibleRedemptionSharesIssued
      contextRef="AsOf2025-11-30_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000510"
      unitRef="Shares">2124077</BKHAU:ClassOdinarySharesSubjectToPossibleRedemptionSharesIssued>
    <BKHAU:ClassOdinarySharesSubjectToPossibleRedemptionSharesOutstanding
      contextRef="AsOf2025-11-30_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000512"
      unitRef="Shares">2124077</BKHAU:ClassOdinarySharesSubjectToPossibleRedemptionSharesOutstanding>
    <us-gaap:Deposits
      contextRef="AsOf2025-06-22"
      decimals="0"
      id="Fact000514"
      unitRef="USD">150000</us-gaap:Deposits>
    <us-gaap:Deposits
      contextRef="AsOf2025-07-15"
      decimals="0"
      id="Fact000516"
      unitRef="USD">150000</us-gaap:Deposits>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000518"
      unitRef="USD">39521</us-gaap:CashEquivalentsAtCarryingValue>
    <BKHAU:WorkingCapitalDeficit
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000520"
      unitRef="USD">1431443</BKHAU:WorkingCapitalDeficit>
    <BKHAU:PaymentsFromSponser
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000522"
      unitRef="USD">25000</BKHAU:PaymentsFromSponser>
    <us-gaap:UnsecuredDebt
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000524"
      unitRef="USD">250000</us-gaap:UnsecuredDebt>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2024-12-01to2025-11-30" id="Fact000528">&lt;p id="xdx_807_eus-gaap--SignificantAccountingPoliciesTextBlock_zlVlQlXsoiqj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 2 &#x2014; &lt;span id="xdx_821_zPNlgCkgNIVl"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--ConsolidationPolicyTextBlock_zGfJOzo7lPMe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86F_zAUgBw1KtPQ7"&gt;Principles of Consolidation&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The consolidated financial statements include
the financial statements of the Company and its wholly owned subsidiaries. All transactions and balances among the Company and its subsidiaries
have been eliminated upon consolidation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_84C_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zKSldx1pJW73" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_869_ziTvg4xJrOf9"&gt;Basis of Presentation&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The accompanying audited financial statements are presented in U.S. Dollars and in conformity the U.S. GAAP and pursuant to the rules and regulations of the SEC. Accordingly, they include all of the information and footnotes required by the U.S. GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. They should be read in conjunction with the Company&#x2019;s Annual Report on Form 10-K, as filed with the SEC on February 7, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;




&lt;p id="xdx_840_ecustom--EmergingGrowthCompanyPolicyTextBlock_zUokJUoDkVok" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_860_zT5cWw89DRQ3"&gt;Emerging Growth Company&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company is an &#x201c;emerging growth company,&#x201d; as defined in Section&#160;2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Further, Section&#160;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt;













&lt;p id="xdx_84A_eus-gaap--UseOfEstimates_zIgwKlxahvP6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_866_ztKULMhLfJN9"&gt;Use of Estimates&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In preparing these financial statements in conformity with U.S. GAAP, the Company&#x2019;s management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported expenses during the reporting period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_840_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zZmbrrf6uWSb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86C_zdSz6o45eOCl"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $&lt;span id="xdx_90D_eus-gaap--CashEquivalentsAtCarryingValue_pp0p0_c20251130__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CashEquivalentsMember_zSmGg995eI8d" title="Cash"&gt;39,521&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--CashEquivalentsAtCarryingValue_pp0p0_c20241130__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CashEquivalentsMember_zPthLDaptwXd" title="Cash"&gt;264,842&lt;/span&gt; in cash and &lt;span id="xdx_90D_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_dn_c20251130_zD7GXU1Blwb5" title="Cash and cash equivalents"&gt;&lt;span id="xdx_901_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_dn_c20241130_zqpxUjBTcW85" title="Cash and cash equivalents"&gt;none&lt;/span&gt;&lt;/span&gt; in cash equivalents as of November 30, 2025 and 2024, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;


&lt;p id="xdx_84A_ecustom--InvestmenstHeldInTrustAccountPolicyTextBlock_zuTvZD7USCYc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_863_zRwCDb1Ihjn1"&gt;Investments Held in Trust Account&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of November 30, 2025 and 2024, the Company had $&lt;span id="xdx_908_eus-gaap--AssetsHeldInTrustNoncurrent_pp0p0_c20251130_zSoF4ICNq8jc" title="Investments held in Trust Account"&gt;23,827,149&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--AssetsHeldInTrustNoncurrent_iI_pp0p0_dn_c20241130_zZpGmnue5af5" title="Investments held in Trust Account"&gt;71,829,264&lt;/span&gt; in investment held in the Trust Account comprised of money market funds that invest in U.S. government securities, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Earnings on investments held in the Trust Account are included in interest earned on investments held in the Trust Account in the accompanying statement of operations. The estimated fair value of investments held in the Trust Account is determined using available market information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_848_ecustom--DeferredOfferingCostPolicyTextBlock_z3TgO0pWUy6c" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_860_zyAAvtHgeFoi"&gt;Deferred Offering Costs&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company complies with the requirements of FASB ASC Topic 340-10-S99-1, &#x201c;Other Assets and Deferred Costs &#x2013; SEC Materials&#x201d; (&#x201c;ASC 340-10-S99&#x201d;) and SEC Staff Accounting Bulletin Topic 5A, &#x201c;Expenses of Offering&#x201d;. Deferred offering costs were $&lt;span id="xdx_902_eus-gaap--DeferredCosts_pp0p0_c20251130_zRRfmKufxEn8" title="Deferred cost"&gt;4,309,493&lt;/span&gt; consisting principally of $&lt;span id="xdx_90B_ecustom--UnderwritingFees_pp0p0_c20241201__20251130_zwaNFCygVsL3" title="Underwriting fees"&gt;3,795,000&lt;/span&gt; underwriting fees $&lt;span id="xdx_905_eus-gaap--LegalFees_pp0p0_c20241201__20251130_z3kKN9DXYKdh" title="Legal and other expense"&gt;514,493&lt;/span&gt; legal and other expenses that are directly related to the IPO and charged to shareholders&#x2019; equity upon the completion of the IPO.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_zGCi3DeugDX6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_866_zKS6wrtKylZe"&gt;Income Taxes&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company follows the asset and liability method of accounting for income taxes under ASC 740, &#x201c;Income Taxes.&#x201d; Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that is included in the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There was &lt;span id="xdx_901_eus-gaap--UnrecognizedTaxBenefits_iI_pp0p0_do_c20251130_zApCpd0pLUGi" title="Unrecognized tax benefits"&gt;no&lt;/span&gt; unrecognized tax benefits, and &lt;span id="xdx_908_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_pp0p0_do_c20251130_zK4x6vpFBPta" title="Accrued for interest and penalties"&gt;no&lt;/span&gt; amounts accrued for interest and penalties as of November 30, 2025. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company&#x2019;s consolidated financial statements.&lt;/p&gt;













&lt;p id="xdx_848_eus-gaap--EarningsPerSharePolicyTextBlock_zuzcpKqLt5b2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_861_zxJJOFl0WRh2"&gt;Net Income (Loss) Per Ordinary Share&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company complies with the accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. Net income per ordinary is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture by the Initial Shareholders. As of November 30, 2025 and 2024, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss) per ordinary share is the same as basic income (loss) per ordinary share for the periods presented.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The calculation of diluted income per ordinary
share does not consider the effect of the rights issued in connection with the (i) IPO, and (ii) the private placement, since the issuance
of the shares included in the rights is contingent upon the occurrence of future events. The rights entitle the holder to receive one-fifth
of one ordinary share representing a total of &lt;span id="xdx_902_ecustom--OrdinaryShares_iI_c20251130_zLAZXSWrPob7" title="Ordinary shares"&gt;1,427,100&lt;/span&gt; ordinary shares.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zgTSnTrJ9Uk5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_zm5UwjprYL74" style="display: none"&gt;Schedule
    of basic income (loss) per share&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_496_20241201__20251130__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zG7gYcOBRGll" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_490_20241201__20251130__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zZFMqXwqpDVd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_498_20231201__20241130__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z3iCEZANAG92" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_497_20231201__20241130__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zbP0sCIrqdWc" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For the Year Ended&lt;br/&gt; November&#160;30,&lt;br/&gt; 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For the Year Ended&lt;br/&gt; November&#160;30,&lt;br/&gt; 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable&lt;br/&gt; shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-&lt;br/&gt; redeemable&lt;br/&gt; shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable&lt;br/&gt; shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-&lt;br/&gt; redeemable&lt;br/&gt; shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--BasicAndDilutedNetPerShareAbstract_iB_zCC5mhyPmnTb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic and diluted net income per ordinary share&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--NumeratorAbstract_iB_zwY6ZhHd1mKe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zfVifSCbA5hc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; width: 52%; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Allocation of net income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;945,846&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;383,711&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,362,723&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;552,980&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--DenominatorAbstract_iB_zpWsfyEjYhCf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--BasicAndDilutedWeightedAverageSharesOutstanding_zbhlqVtad792" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic and diluted weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,002,716&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,029,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,769,672&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,935,488&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--BasicAndDilutedNetIncomeLossPerOrdinaryShare_zqqwfT3W2Izl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic and diluted net income per ordinary share&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.19&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.19&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.29&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.29&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8A2_zN26rH5CXqs2" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zCz4c4G9oZq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_862_zNatAELTwBKb"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $&lt;span id="xdx_900_eus-gaap--CashFDICInsuredAmount_pp0p0_c20251130_zAMxBADSgDU9" title="FDIC Coverage limit"&gt;250,000&lt;/span&gt;. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account as of November 30, 2025 and 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_849_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zECQ1wk6P138" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_865_zGeugIOjaj04"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC 825, &#x201c;Financial Instruments,&#x201d; approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_840_ecustom--RelatedPartyPolicyTextBlock_zxctpPmwI2e4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86E_zvvcgcN8l2T"&gt;Related Party&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Parties, which can be a corporation or individual,
are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant
influence over the other party in making financial and operational decisions. Companies are also considered to be related if they are
subject to common control or common significant influence.&lt;/p&gt;














&lt;p id="xdx_847_ecustom--OrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock_zSdbXu8dl08" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Ordinary Shares Subject to Possible Redemption&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 &#x201c;Distinguishing Liabilities from Equity.&#x201d; Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#x2019;s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders&#x2019; equity. The Company&#x2019;s ordinary shares feature certain redemption rights that are considered to be outside of the Company&#x2019;s control and subject to the occurrence of uncertain future events. If it is probable that the equity instrument will become redeemable, we have the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_846_ecustom--ConvertiblePromissoryNotesAndDerivativeLiabilitiesPolicyTextBlock_zwBVcTYrTnRf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86E_zV74ho4xCBLj"&gt;Convertible Promissory Notes and Derivative
Liabilities&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for convertible promissory
notes under ASC 470 &#x201c;Debt&#x201d; and evaluates embedded features under ASC 815 &#x201c;Derivatives and Hedging&#x201d;. Sponsor or
affiliate loans may be converted into ordinary shares upon completion of a Business Combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;If the conversion option has a fixed conversion
price and meets the &#x201c;own-equity&#x201d; scope exception in ASC 815-40, the note is accounted for as a single debt instrument. If
the conversion price is variable or indexed to the target company&#x2019;s equity, the conversion feature is bifurcated and recorded as
a derivative liability, initially measured and subsequently remeasured at fair value each reporting period, with changes recognized in
earnings. The debt host is recorded at the residual amount and amortized to face value using the effective interest method. Convertible
notes and derivative liabilities are classified as current liabilities if settlement or conversion is expected within one year. Fair
value is estimated using the Black-Scholes, Binomial, or Monte Carlo models and is categorized as Level 3 under ASC 820.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;




&lt;p id="xdx_84D_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zcBrJugEA9v2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_866_zmUTTQRrcSgb"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company&#x2019;s financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;


</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2024-12-01to2025-11-30" id="Fact000530">&lt;p id="xdx_84D_eus-gaap--ConsolidationPolicyTextBlock_zGfJOzo7lPMe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86F_zAUgBw1KtPQ7"&gt;Principles of Consolidation&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The consolidated financial statements include
the financial statements of the Company and its wholly owned subsidiaries. All transactions and balances among the Company and its subsidiaries
have been eliminated upon consolidation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;



</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2024-12-01to2025-11-30" id="Fact000532">&lt;p id="xdx_84C_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zKSldx1pJW73" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_869_ziTvg4xJrOf9"&gt;Basis of Presentation&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The accompanying audited financial statements are presented in U.S. Dollars and in conformity the U.S. GAAP and pursuant to the rules and regulations of the SEC. Accordingly, they include all of the information and footnotes required by the U.S. GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. They should be read in conjunction with the Company&#x2019;s Annual Report on Form 10-K, as filed with the SEC on February 7, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;




</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <BKHAU:EmergingGrowthCompanyPolicyTextBlock contextRef="From2024-12-01to2025-11-30" id="Fact000534">&lt;p id="xdx_840_ecustom--EmergingGrowthCompanyPolicyTextBlock_zUokJUoDkVok" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_860_zT5cWw89DRQ3"&gt;Emerging Growth Company&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company is an &#x201c;emerging growth company,&#x201d; as defined in Section&#160;2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Further, Section&#160;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt;













</BKHAU:EmergingGrowthCompanyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2024-12-01to2025-11-30" id="Fact000538">&lt;p id="xdx_84A_eus-gaap--UseOfEstimates_zIgwKlxahvP6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_866_ztKULMhLfJN9"&gt;Use of Estimates&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In preparing these financial statements in conformity with U.S. GAAP, the Company&#x2019;s management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported expenses during the reporting period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2024-12-01to2025-11-30" id="Fact000540">&lt;p id="xdx_840_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zZmbrrf6uWSb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86C_zdSz6o45eOCl"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $&lt;span id="xdx_90D_eus-gaap--CashEquivalentsAtCarryingValue_pp0p0_c20251130__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CashEquivalentsMember_zSmGg995eI8d" title="Cash"&gt;39,521&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--CashEquivalentsAtCarryingValue_pp0p0_c20241130__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CashEquivalentsMember_zPthLDaptwXd" title="Cash"&gt;264,842&lt;/span&gt; in cash and &lt;span id="xdx_90D_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_dn_c20251130_zD7GXU1Blwb5" title="Cash and cash equivalents"&gt;&lt;span id="xdx_901_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_dn_c20241130_zqpxUjBTcW85" title="Cash and cash equivalents"&gt;none&lt;/span&gt;&lt;/span&gt; in cash equivalents as of November 30, 2025 and 2024, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;


</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="AsOf2025-11-30_us-gaap_CashEquivalentsMember"
      decimals="0"
      id="Fact000542"
      unitRef="USD">39521</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="AsOf2024-11-30_us-gaap_CashEquivalentsMember"
      decimals="0"
      id="Fact000544"
      unitRef="USD">264842</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000546"
      unitRef="USD">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000548"
      unitRef="USD">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <BKHAU:InvestmenstHeldInTrustAccountPolicyTextBlock contextRef="From2024-12-01to2025-11-30" id="Fact000550">&lt;p id="xdx_84A_ecustom--InvestmenstHeldInTrustAccountPolicyTextBlock_zuTvZD7USCYc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_863_zRwCDb1Ihjn1"&gt;Investments Held in Trust Account&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of November 30, 2025 and 2024, the Company had $&lt;span id="xdx_908_eus-gaap--AssetsHeldInTrustNoncurrent_pp0p0_c20251130_zSoF4ICNq8jc" title="Investments held in Trust Account"&gt;23,827,149&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--AssetsHeldInTrustNoncurrent_iI_pp0p0_dn_c20241130_zZpGmnue5af5" title="Investments held in Trust Account"&gt;71,829,264&lt;/span&gt; in investment held in the Trust Account comprised of money market funds that invest in U.S. government securities, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Earnings on investments held in the Trust Account are included in interest earned on investments held in the Trust Account in the accompanying statement of operations. The estimated fair value of investments held in the Trust Account is determined using available market information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



</BKHAU:InvestmenstHeldInTrustAccountPolicyTextBlock>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000552"
      unitRef="USD">23827149</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000554"
      unitRef="USD">71829264</us-gaap:AssetsHeldInTrustNoncurrent>
    <BKHAU:DeferredOfferingCostPolicyTextBlock contextRef="From2024-12-01to2025-11-30" id="Fact000556">&lt;p id="xdx_848_ecustom--DeferredOfferingCostPolicyTextBlock_z3TgO0pWUy6c" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_860_zyAAvtHgeFoi"&gt;Deferred Offering Costs&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company complies with the requirements of FASB ASC Topic 340-10-S99-1, &#x201c;Other Assets and Deferred Costs &#x2013; SEC Materials&#x201d; (&#x201c;ASC 340-10-S99&#x201d;) and SEC Staff Accounting Bulletin Topic 5A, &#x201c;Expenses of Offering&#x201d;. Deferred offering costs were $&lt;span id="xdx_902_eus-gaap--DeferredCosts_pp0p0_c20251130_zRRfmKufxEn8" title="Deferred cost"&gt;4,309,493&lt;/span&gt; consisting principally of $&lt;span id="xdx_90B_ecustom--UnderwritingFees_pp0p0_c20241201__20251130_zwaNFCygVsL3" title="Underwriting fees"&gt;3,795,000&lt;/span&gt; underwriting fees $&lt;span id="xdx_905_eus-gaap--LegalFees_pp0p0_c20241201__20251130_z3kKN9DXYKdh" title="Legal and other expense"&gt;514,493&lt;/span&gt; legal and other expenses that are directly related to the IPO and charged to shareholders&#x2019; equity upon the completion of the IPO.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



</BKHAU:DeferredOfferingCostPolicyTextBlock>
    <us-gaap:DeferredCosts
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000558"
      unitRef="USD">4309493</us-gaap:DeferredCosts>
    <BKHAU:UnderwritingFees
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000560"
      unitRef="USD">3795000</BKHAU:UnderwritingFees>
    <us-gaap:LegalFees
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000562"
      unitRef="USD">514493</us-gaap:LegalFees>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2024-12-01to2025-11-30" id="Fact000564">&lt;p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_zGCi3DeugDX6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_866_zKS6wrtKylZe"&gt;Income Taxes&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company follows the asset and liability method of accounting for income taxes under ASC 740, &#x201c;Income Taxes.&#x201d; Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that is included in the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There was &lt;span id="xdx_901_eus-gaap--UnrecognizedTaxBenefits_iI_pp0p0_do_c20251130_zApCpd0pLUGi" title="Unrecognized tax benefits"&gt;no&lt;/span&gt; unrecognized tax benefits, and &lt;span id="xdx_908_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_pp0p0_do_c20251130_zK4x6vpFBPta" title="Accrued for interest and penalties"&gt;no&lt;/span&gt; amounts accrued for interest and penalties as of November 30, 2025. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company&#x2019;s consolidated financial statements.&lt;/p&gt;













</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000566"
      unitRef="USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000568"
      unitRef="USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2024-12-01to2025-11-30" id="Fact000572">&lt;p id="xdx_848_eus-gaap--EarningsPerSharePolicyTextBlock_zuzcpKqLt5b2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_861_zxJJOFl0WRh2"&gt;Net Income (Loss) Per Ordinary Share&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company complies with the accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. Net income per ordinary is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture by the Initial Shareholders. As of November 30, 2025 and 2024, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss) per ordinary share is the same as basic income (loss) per ordinary share for the periods presented.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The calculation of diluted income per ordinary
share does not consider the effect of the rights issued in connection with the (i) IPO, and (ii) the private placement, since the issuance
of the shares included in the rights is contingent upon the occurrence of future events. The rights entitle the holder to receive one-fifth
of one ordinary share representing a total of &lt;span id="xdx_902_ecustom--OrdinaryShares_iI_c20251130_zLAZXSWrPob7" title="Ordinary shares"&gt;1,427,100&lt;/span&gt; ordinary shares.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zgTSnTrJ9Uk5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_zm5UwjprYL74" style="display: none"&gt;Schedule
    of basic income (loss) per share&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_496_20241201__20251130__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zG7gYcOBRGll" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_490_20241201__20251130__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zZFMqXwqpDVd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_498_20231201__20241130__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z3iCEZANAG92" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_497_20231201__20241130__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zbP0sCIrqdWc" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For the Year Ended&lt;br/&gt; November&#160;30,&lt;br/&gt; 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For the Year Ended&lt;br/&gt; November&#160;30,&lt;br/&gt; 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable&lt;br/&gt; shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-&lt;br/&gt; redeemable&lt;br/&gt; shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable&lt;br/&gt; shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-&lt;br/&gt; redeemable&lt;br/&gt; shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--BasicAndDilutedNetPerShareAbstract_iB_zCC5mhyPmnTb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic and diluted net income per ordinary share&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--NumeratorAbstract_iB_zwY6ZhHd1mKe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zfVifSCbA5hc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; width: 52%; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Allocation of net income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;945,846&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;383,711&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,362,723&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;552,980&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--DenominatorAbstract_iB_zpWsfyEjYhCf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--BasicAndDilutedWeightedAverageSharesOutstanding_zbhlqVtad792" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic and diluted weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,002,716&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,029,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,769,672&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,935,488&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--BasicAndDilutedNetIncomeLossPerOrdinaryShare_zqqwfT3W2Izl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic and diluted net income per ordinary share&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.19&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.19&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.29&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.29&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8A2_zN26rH5CXqs2" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



</us-gaap:EarningsPerSharePolicyTextBlock>
    <BKHAU:OrdinaryShares
      contextRef="AsOf2025-11-30"
      decimals="INF"
      id="Fact000574"
      unitRef="Shares">1427100</BKHAU:OrdinaryShares>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2024-12-01to2025-11-30" id="Fact000576">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zgTSnTrJ9Uk5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_zm5UwjprYL74" style="display: none"&gt;Schedule
    of basic income (loss) per share&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_496_20241201__20251130__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zG7gYcOBRGll" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_490_20241201__20251130__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zZFMqXwqpDVd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_498_20231201__20241130__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z3iCEZANAG92" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_497_20231201__20241130__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zbP0sCIrqdWc" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For the Year Ended&lt;br/&gt; November&#160;30,&lt;br/&gt; 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For the Year Ended&lt;br/&gt; November&#160;30,&lt;br/&gt; 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable&lt;br/&gt; shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-&lt;br/&gt; redeemable&lt;br/&gt; shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable&lt;br/&gt; shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-&lt;br/&gt; redeemable&lt;br/&gt; shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--BasicAndDilutedNetPerShareAbstract_iB_zCC5mhyPmnTb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic and diluted net income per ordinary share&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--NumeratorAbstract_iB_zwY6ZhHd1mKe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zfVifSCbA5hc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; width: 52%; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Allocation of net income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;945,846&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;383,711&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,362,723&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;552,980&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--DenominatorAbstract_iB_zpWsfyEjYhCf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--BasicAndDilutedWeightedAverageSharesOutstanding_zbhlqVtad792" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic and diluted weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,002,716&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,029,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,769,672&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,935,488&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--BasicAndDilutedNetIncomeLossPerOrdinaryShare_zqqwfT3W2Izl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic and diluted net income per ordinary share&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.19&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.19&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.29&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.29&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-12-012025-11-30_custom_RedeemableSharesMember"
      decimals="0"
      id="Fact000588"
      unitRef="USD">945846</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-12-012025-11-30_custom_NonRedeemableSharesMember"
      decimals="0"
      id="Fact000589"
      unitRef="USD">383711</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-12-012024-11-30_custom_RedeemableSharesMember"
      decimals="0"
      id="Fact000590"
      unitRef="USD">1362723</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-12-012024-11-30_custom_NonRedeemableSharesMember"
      decimals="0"
      id="Fact000591"
      unitRef="USD">552980</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <BKHAU:BasicAndDilutedWeightedAverageSharesOutstanding
      contextRef="From2024-12-012025-11-30_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000598"
      unitRef="Shares">5002716</BKHAU:BasicAndDilutedWeightedAverageSharesOutstanding>
    <BKHAU:BasicAndDilutedWeightedAverageSharesOutstanding
      contextRef="From2024-12-012025-11-30_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000599"
      unitRef="Shares">2029500</BKHAU:BasicAndDilutedWeightedAverageSharesOutstanding>
    <BKHAU:BasicAndDilutedWeightedAverageSharesOutstanding
      contextRef="From2023-12-012024-11-30_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000600"
      unitRef="Shares">4769672</BKHAU:BasicAndDilutedWeightedAverageSharesOutstanding>
    <BKHAU:BasicAndDilutedWeightedAverageSharesOutstanding
      contextRef="From2023-12-012024-11-30_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000601"
      unitRef="Shares">1935488</BKHAU:BasicAndDilutedWeightedAverageSharesOutstanding>
    <BKHAU:BasicAndDilutedNetIncomeLossPerOrdinaryShare
      contextRef="From2024-12-012025-11-30_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000603"
      unitRef="USDPShares">0.19</BKHAU:BasicAndDilutedNetIncomeLossPerOrdinaryShare>
    <BKHAU:BasicAndDilutedNetIncomeLossPerOrdinaryShare
      contextRef="From2024-12-012025-11-30_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000604"
      unitRef="USDPShares">0.19</BKHAU:BasicAndDilutedNetIncomeLossPerOrdinaryShare>
    <BKHAU:BasicAndDilutedNetIncomeLossPerOrdinaryShare
      contextRef="From2023-12-012024-11-30_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000605"
      unitRef="USDPShares">0.29</BKHAU:BasicAndDilutedNetIncomeLossPerOrdinaryShare>
    <BKHAU:BasicAndDilutedNetIncomeLossPerOrdinaryShare
      contextRef="From2023-12-012024-11-30_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000606"
      unitRef="USDPShares">0.29</BKHAU:BasicAndDilutedNetIncomeLossPerOrdinaryShare>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2024-12-01to2025-11-30" id="Fact000608">&lt;p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zCz4c4G9oZq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_862_zNatAELTwBKb"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $&lt;span id="xdx_900_eus-gaap--CashFDICInsuredAmount_pp0p0_c20251130_zAMxBADSgDU9" title="FDIC Coverage limit"&gt;250,000&lt;/span&gt;. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account as of November 30, 2025 and 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashFDICInsuredAmount
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000610"
      unitRef="USD">250000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2024-12-01to2025-11-30" id="Fact000612">&lt;p id="xdx_849_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zECQ1wk6P138" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_865_zGeugIOjaj04"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC 825, &#x201c;Financial Instruments,&#x201d; approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <BKHAU:RelatedPartyPolicyTextBlock contextRef="From2024-12-01to2025-11-30" id="Fact000614">&lt;p id="xdx_840_ecustom--RelatedPartyPolicyTextBlock_zxctpPmwI2e4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86E_zvvcgcN8l2T"&gt;Related Party&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Parties, which can be a corporation or individual,
are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant
influence over the other party in making financial and operational decisions. Companies are also considered to be related if they are
subject to common control or common significant influence.&lt;/p&gt;














</BKHAU:RelatedPartyPolicyTextBlock>
    <BKHAU:OrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock contextRef="From2024-12-01to2025-11-30" id="Fact000618">&lt;p id="xdx_847_ecustom--OrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock_zSdbXu8dl08" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Ordinary Shares Subject to Possible Redemption&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 &#x201c;Distinguishing Liabilities from Equity.&#x201d; Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#x2019;s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders&#x2019; equity. The Company&#x2019;s ordinary shares feature certain redemption rights that are considered to be outside of the Company&#x2019;s control and subject to the occurrence of uncertain future events. If it is probable that the equity instrument will become redeemable, we have the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</BKHAU:OrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock>
    <BKHAU:ConvertiblePromissoryNotesAndDerivativeLiabilitiesPolicyTextBlock contextRef="From2024-12-01to2025-11-30" id="Fact000620">&lt;p id="xdx_846_ecustom--ConvertiblePromissoryNotesAndDerivativeLiabilitiesPolicyTextBlock_zwBVcTYrTnRf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86E_zV74ho4xCBLj"&gt;Convertible Promissory Notes and Derivative
Liabilities&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for convertible promissory
notes under ASC 470 &#x201c;Debt&#x201d; and evaluates embedded features under ASC 815 &#x201c;Derivatives and Hedging&#x201d;. Sponsor or
affiliate loans may be converted into ordinary shares upon completion of a Business Combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;If the conversion option has a fixed conversion
price and meets the &#x201c;own-equity&#x201d; scope exception in ASC 815-40, the note is accounted for as a single debt instrument. If
the conversion price is variable or indexed to the target company&#x2019;s equity, the conversion feature is bifurcated and recorded as
a derivative liability, initially measured and subsequently remeasured at fair value each reporting period, with changes recognized in
earnings. The debt host is recorded at the residual amount and amortized to face value using the effective interest method. Convertible
notes and derivative liabilities are classified as current liabilities if settlement or conversion is expected within one year. Fair
value is estimated using the Black-Scholes, Binomial, or Monte Carlo models and is categorized as Level 3 under ASC 820.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;




</BKHAU:ConvertiblePromissoryNotesAndDerivativeLiabilitiesPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2024-12-01to2025-11-30" id="Fact000622">&lt;p id="xdx_84D_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zcBrJugEA9v2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_866_zmUTTQRrcSgb"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company&#x2019;s financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;


</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <BKHAU:ProposedPublicOfferingTextBlock contextRef="From2024-12-01to2025-11-30" id="Fact000624">&lt;p id="xdx_806_ecustom--ProposedPublicOfferingTextBlock_zHlyaXh8pQkg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 3 &#x2014; &lt;span&gt;&lt;span id="xdx_82E_z9nY8IY4X5lk"&gt;Initial Public Offering&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On March&#160;22, 2024, the Company sold &lt;span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240301__20240322__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zXiUFe8kv7Sk" title="Sale of units in public offering"&gt;6,900,000&lt;/span&gt; Units at a price of $&lt;span id="xdx_908_eus-gaap--SaleOfStockPricePerShare_iI_c20240322__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zYao8PhnnXE5" title="Sale of units per share"&gt;10.00&lt;/span&gt; per Unit generating gross proceeds of $&lt;span id="xdx_90D_ecustom--GrossProceedsFromInitialPublicOffering_pp0p0_c20240301__20240322__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zitafqXrfNFk" title="Gross proceeds from Initial Public Offering"&gt;69,000,000&lt;/span&gt;. Each Unit consists of one Class A ordinary share and one-fifth (1/5) of one right (&#x201c;Public Right&#x201d;). Each Public Right will convert into one Class A ordinary share upon the consummation of a Business Combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



</BKHAU:ProposedPublicOfferingTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-03-012024-03-22_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000626"
      unitRef="Shares">6900000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2024-03-22_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000628"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <BKHAU:GrossProceedsFromInitialPublicOffering
      contextRef="From2024-03-012024-03-22_us-gaap_IPOMember"
      decimals="0"
      id="Fact000630"
      unitRef="USD">69000000</BKHAU:GrossProceedsFromInitialPublicOffering>
    <BKHAU:PrivatePlacementTextBlock contextRef="From2024-12-01to2025-11-30" id="Fact000632">&lt;p id="xdx_807_ecustom--PrivatePlacementTextBlock_ztx6vvhxXFGf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 4 &#x2014; &lt;span&gt;&lt;span id="xdx_82E_zZ4Kr0R0FPCi"&gt;Private Placement&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of &lt;span id="xdx_901_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240301__20240322__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zlVcb6TCNayc" title="Sale of units in initial public offering"&gt;235,500&lt;/span&gt; Private Units at a price of $&lt;span id="xdx_90B_eus-gaap--SaleOfStockPricePerShare_iI_c20240322__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zzQk8qBA5ZAl" title="Sale of units per share"&gt;10.00&lt;/span&gt; per Private Unit for an aggregate purchase price of $&lt;span id="xdx_905_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240301__20240322__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_ziVJrtw71Hnh" title="Sale of units in initial public offering aggregate amount"&gt;2,355,000&lt;/span&gt; in a private placement. The Private Units are identical to the Public Units except with respect to certain registration rights and transfer restrictions. Each Private Unit will consist of one Class A ordinary share (&#x201c;Private Share&#x201d;) and one-fifth (1/5) of one right (&#x201c;Private Right&#x201d;). Each Private Right will convert into one Class A ordinary share upon the consummation of a Business Combination. The proceeds from the Private Units will be added to the proceeds from the Proposed Public Offering to be held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Units and all underlying securities will expire worthless.&lt;/p&gt;













</BKHAU:PrivatePlacementTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-03-012024-03-22_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000634"
      unitRef="Shares">235500</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2024-03-22_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000636"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2024-03-012024-03-22_us-gaap_PrivatePlacementMember"
      decimals="0"
      id="Fact000638"
      unitRef="USD">2355000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2024-12-01to2025-11-30" id="Fact000642">&lt;p id="xdx_80A_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zDMOiWNB6vlk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 5 &#x2014; &lt;span&gt;&lt;span id="xdx_825_zMJdALTLSyed"&gt;&lt;span id="xdx_822_zIz2hEWTk9ob"&gt;Related Party Transactions&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Founder Shares&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On October&#160;16, 2023, the Company issued &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20231001__20231016__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_z2uLLOj5QCCg" title="Number of shares issued, shares"&gt;17,250,000&lt;/span&gt; shares of Class B ordinary shares, $&lt;span id="xdx_907_eus-gaap--SharePrice_iI_c20231016__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zJSnB6MP9Vi1" title="Share Price"&gt;0.0001&lt;/span&gt; per share to the Sponsor (&#x201c;Founder Shares&#x201d;), for an aggregated consideration of $&lt;span id="xdx_904_ecustom--AggregatedConsideration_c20231001__20231016__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember_z51gf8T6GCMa" title="Aggregated consideration"&gt;25,000&lt;/span&gt;, or approximately $&lt;span id="xdx_906_eus-gaap--SharePrice_iI_c20231016__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember_zCmYn7WFdCHc" title="Share Price"&gt;0.0145&lt;/span&gt; per share. On November&#160;13, 2023, the Company and the Sponsor entered into the First Amendment to the Subscription Agreement, pursuant to which the &lt;span id="xdx_909_eus-gaap--ConversionOfStockSharesConverted1_c20231001__20231016__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember_zZOrIiZEQ9Zj" title="Converted common shares"&gt;17,250,000&lt;/span&gt; shares of common stock were converted to &lt;span id="xdx_90B_eus-gaap--ConversionOfStockSharesConverted1_c20231001__20231016__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zG4pKnVxzJG2" title="Converted common shares"&gt;1,725,000&lt;/span&gt; Class B ordinary shares. On March&#160;18, 2024, the Company elected to convert &lt;span id="xdx_905_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20240318__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zu3ND6khPpJh" title="Converted common shares"&gt;1,725,000&lt;/span&gt; Class B ordinary shares into &lt;span id="xdx_901_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20240318__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_znMRSOgYm68h" title="Converted common shares"&gt;1,725,000&lt;/span&gt; Class A ordinary shares upon the closing of IPO. On March&#160;20, 2024, the Company and the Sponsor entered into the Second Amendment to the Subscription Agreement, pursuant to which the purchased amount of shares was adjusted to &lt;span id="xdx_90A_ecustom--AdjustedClassBOrdinaryShares_c20240301__20240320_z8nq6TAW0HXl" title="Adjusted class B ordinary shares"&gt;1,983,750&lt;/span&gt; Class B ordinary shares, $&lt;span id="xdx_909_eus-gaap--SaleOfStockPricePerShare_iI_c20240320_zTdpxPeh4Yka" title="Sale of units per share"&gt;0.0126&lt;/span&gt; par value per ordinary share. As of November&#160;30, 2025 and November 30, 2024, there were &lt;span id="xdx_90B_ecustom--FounderSharesIssued_c20251130_zTjXIUuv4OW8" title="Founder shares issued"&gt;&lt;span id="xdx_900_ecustom--FounderSharesOutstanding_c20251130_zSKsSvQvXU32" title="Founder shares outstanding"&gt;&lt;span id="xdx_906_ecustom--FounderSharesIssued_iI_c20241130_zUVtmH2AZzx8" title="Founder shares issued"&gt;&lt;span id="xdx_909_ecustom--FounderSharesOutstanding_iI_c20241130_zUrem78MHZ08" title="Founder shares outstanding"&gt;1,725,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; Founder Shares issued and outstanding.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Initial Shareholders have agreed, subject to certain limited exceptions, not to transfer, assign or sell any of their Founder Shares for a time period ending on the date that is the earlier of (A) six months after the completion of the Company&#x2019;s initial business combination or (B) the date on which we complete a liquidation, merger, stock exchange or other similar transaction after our initial business combination that results in all of the public shareholders having the right to exchange their shares of ordinary shares for cash, securities or other property. Notwithstanding the foregoing, the converted shares of our Class A ordinary shares will be released from the lock-up if (1) the last reported sale price of the Company&#x2019;s Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and other similar transactions) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial business combination or (2) if the Company complete a transaction after the initial business combination which results in all of the shareholders having the right to exchange their shares for cash, securities or other property. The Initial Shareholders also agree not to transfer any ownership interest in, except to permitted transferees, their private placement until at least 30 days following the completion of the business combination. However, if after a business combination there is a transaction whereby all the outstanding shares are exchanged or redeemed for cash (as would be the case in a post-asset sale liquidation) or another issuer&#x2019;s shares, then the Founder Shares or the private placement units (or any shares of ordinary shares thereunder) shall be permitted to participate.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Due from Related Party&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company reimbursed the Sponsor for its payment of $&lt;span id="xdx_901_eus-gaap--ProfessionalFees_pp0p0_c20241201__20251130_zjDEFkKYesxe"&gt;30,900 &lt;/span&gt;professional fees to a service provider which is no longer engaged by the Company. The amount was unsecured, interest-free and due on demand, which was offset with the repayment of the Promissory Note on March&#160;25, 2024. As of November&#160;30, 2025 and 2024, the Company had no amount due from related party.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Promissory Note &#x2014; Related Party&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On October&#160;16, 2023, the Sponsor agreed to loan the Company up to an aggregate amount of $&lt;span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_c20231016_pp0p0"&gt;250,000 &lt;/span&gt;to be used, in part, for transaction costs incurred in connection with the Proposed Public Offering (the &#x201c;Promissory Note&#x201d;). The Promissory Note is unsecured, interest-free and due on the earlier of: (i) September&#160;30, 2024 or (ii) the date on which the Company closes the IPO. The entire loan amount was repaid by the Company on March&#160;25, 2024. The Company had no borrowings under the Promissory Note as of November&#160;30, 2025 and 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;Convertible Notes &#x2014; Related Party&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On June 13, 2025 and September 23, 2025, the Company issued convertible
promissory notes to the Sponsor (the &#x201c;June Note&#x201d; and the &#x201c;September Note,&#x201d; and collectively, the &#x201c;Convertible
Notes&#x201d;), &lt;span id="xdx_90A_ecustom--ConvertiblePromissoryNotes_c20241201__20251130_zATDLgZVMfpb" title="Convertible promissory notes"&gt;each permitting borrowings of up to $350,000. As of November 30, 2025, the Company had drawn $350,000 under the June Note
and $250,000 under the September Note.&lt;/span&gt;&lt;/p&gt;









&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The June Note bears interest at 6% per annum and the September Note bears interest at 10% per annum. The Convertible Notes are unsecured and mature on the earlier of (i) the consummation of a business combination or (ii) the Company&#x2019;s liquidation date, as approved by stockholders. Upon consummation of a business combination, the Sponsor may elect to convert any unpaid principal and accrued interest into ordinary shares of the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The conversion price was defined as the most favorable price per share, conversion rate, or valuation assigned to any equity securities issued by the target company in connection with the DeSPAC transaction to any third party during the thirty-six (36) months preceding conversion. Because the conversion price was variable and based on the valuation of equity securities issued by the target company, the embedded conversion feature did not qualify for the equity scope exception under ASC 815-40. Accordingly, the conversion feature was bifurcated and recorded as a derivative liability at fair value, with changes in fair value recognized in earnings.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On September 30, 2025, the Convertible Notes were
modified such that the conversion feature became convertible solely into the Company&#x2019;s own ordinary shares at a fixed conversion
price of $1.00 per share, which represents one-tenth (1/10) of the Company&#x2019;s $10.00 initial public offering price per unit. Following
the modification, the conversion option met the equity scope exception under ASC 815-40, and the Convertible Notes were accounted for
as debt with no further fair value remeasurement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Upon the modification of the Convertible Notes
on September 30, 2025, the conversion feature was revised such that it met the equity scope exception under ASC 815-40. As a result, the
embedded derivative no longer required separate liability classification. The carrying amount of the derivative liability as of the modification
date was reclassified to additional paid-in capital.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;For the year ended November 30, 2025, the Company
recognized changes in fair value of the derivative liability through the date of modification. As of November 30, 2025, there was no derivative
liability outstanding.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of November&#160;30, 2025, the outstanding
principal balance under the Convertible Notes was $595,369, including unamortized discount of $&lt;span id="xdx_90A_eus-gaap--DebtInstrumentCarryingAmount_iI_c20251130_zzWZEJhpzBs5" title="Unamortized discount"&gt;4,538 &lt;/span&gt;and accrued interest of $&lt;span id="xdx_903_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_c20251130_zuTpZLcXsEol" title="Accrued interest"&gt;15,454&lt;/span&gt;. There was no convertible note outstanding as of November 30, 2024.
&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;b&gt;June Convertible Note&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;At issuance, the Company recorded a debt discount of $&lt;span id="xdx_90F_ecustom--DebtDiscount_iI_c20251130_zynQOrsErho6" title="Debt discount"&gt;3,244&lt;/span&gt;, representing the fair value of the embedded conversion option.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;At September&#160;30, 2025, the derivative liability was measured at $&lt;span id="xdx_902_eus-gaap--DerivativeFairValueOfDerivativeLiability_iI_c20250930_zNhNWsWr3iMa" title="Derivative liability"&gt;3,177&lt;/span&gt;, compared to $&lt;span id="xdx_906_eus-gaap--DerivativeFairValueOfDerivativeLiability_iI_c20250831_zH3Am8pSusvj" title="Derivative liability"&gt;3,244&lt;/span&gt; at issuance, resulting in a derivative gain of $&lt;span id="xdx_90D_ecustom--NonCashLoss_iI_c20250831_zTHJXsocdrN" title="Non cash loss"&gt;67&lt;/span&gt; recognized in &#x201c;Change in fair value of derivative liability.&#x201d; Interest expense of approximately $&lt;span id="xdx_903_eus-gaap--InterestExpense_c20241201__20251130__us-gaap--ShortTermDebtTypeAxis__custom--JuneConvertibleNoteMember_zbKhPYQeGqD6" title="Interest expense"&gt;9,838&lt;/span&gt; was incurred and accrued for the year ended November 30, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The fair value of the conversion feature was estimated
at the as converted value at September 30, 2025 and initial measurement date of June 13, 2025 to be $&lt;span id="xdx_905_ecustom--FairValueOfConversion_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_z0e7I3DJjNvh" title="Fair value of the conversion"&gt;3,177&lt;/span&gt; and $&lt;span id="xdx_909_ecustom--FairValueOfConversion_c20241201__20250613__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zyZXmexMkpy4" title="Fair value of the conversion"&gt;3,244&lt;/span&gt;, respectively. The
binomial tree model was used based on the following key assumptions:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfFairValueOfTheConversionFeatureAssumptionsTableTextBlock_hus-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zWMkNdZe3gkd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related Party Transactions (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&lt;span id="xdx_8B6_zVkgODueIZD2" style="display: none"&gt;Schedule
    of fair value of the conversion feature assumptions&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;At Issuance &#x96;&lt;br/&gt;
June&#160;13,&lt;br/&gt;
2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;At&lt;br/&gt;
September&#160;30,&lt;br/&gt;
2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; width: 76%; vertical-align: top"&gt;Strike Price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--StrikePrice_iI_c20250613__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zc7mcXvVdsJb" style="width: 9%; text-align: right" title="Strike Price"&gt;1.88&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--StrikePrice_iI_c20250930__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zHlx01zjPdsd" style="width: 9%; text-align: right" title="Strike Price"&gt;1.88&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;Stock Price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SaleOfStockPricePerShare_iI_c20250613__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zb9DRY563oR3" style="text-align: right" title="Stock Price"&gt;1.88&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SaleOfStockPricePerShare_iI_c20250930__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_znJlGh6IV6b" style="text-align: right" title="Stock Price"&gt;1.88&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Time to maturity (in year)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20241201__20250613__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_z3mbUSbhuwTg" title="Time to maturity (in year)"&gt;0.53&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_z151opfBOMeb" title="Time to maturity (in year)"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Business combination success rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--BusinessCombinationSuccessRate_dp_c20241201__20250613__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zw5dyJt6Ev67" title="Business combination success rate"&gt;32.14&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--BusinessCombinationSuccessRate_dp_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zNGtQUSUrcie" title="Business combination success rate"&gt;32.79&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Expected Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20241201__20250613__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zurh5DhxrWA" title="Expected Volatility"&gt;5.7&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zkLZEIQ1VCcd" title="Expected Volatility"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Expected dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20241201__20250613__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zEzrXDFLyEhl" title="Expected dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zrVTkEwlUBih" title="Expected dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20241201__20250613__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_z0kuNhqiFYLk" title="Risk-free rate"&gt;4.02&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zLSojALL7s7f" title="Risk-free rate"&gt;3.68&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zqawYn2xrfrd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;







&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table presents the changes in the
fair value of the Level 3 Derivative liability - Convertible Note conversion option:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_hus-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_z6l6eJ91Jizj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related Party Transactions (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8BE_zJfhjfE4CVF3" style="display: none"&gt;Schedule of Derivative Liabilities at fair value&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;Fair value as of November 30, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iS_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zjI7XoVMC1x2" style="text-align: right" title="Change in fair value, beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0729"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left"&gt;Initial recognition at issuance (June 13, 2025)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--InitialRecognitionAtIssuance_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zVrHydvd3rYh" style="width: 9%; text-align: right" title="Initial recognition at issuance"&gt;3,244&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;Change in valuation recognized in earnings&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ChangeInValuationRecognizedInEarnings_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_z34PcGLPH473" style="border-bottom: Black 1pt solid; text-align: right" title="Change in valuation recognized in earnings"&gt;(67&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt; vertical-align: top"&gt;Fair value as of September 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LiabilitiesFairValueDisclosure_iE_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zBpl8OdL0YM1" style="border-bottom: Black 2.5pt double; text-align: right" title="Change in fair value, ending"&gt;3,177&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zpm0YGPkf6cd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;&lt;b&gt;September Convertible Note&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;At issuance, the Company recorded a debt discount of $&lt;span id="xdx_901_ecustom--DebtDiscount_iI_c20250930_zE5idDSoPW09" title="Debt discount"&gt;1,387&lt;/span&gt;, representing the fair value of the embedded conversion option related to the $&lt;span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20250930_zWS7H7X7VKP5" title="Principal amount"&gt;150,000&lt;/span&gt; funded principal amount.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;At September 30, 2025, the derivative liability was measured at $&lt;span id="xdx_904_eus-gaap--DerivativeFairValueOfDerivativeLiability_iI_c20250930__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zOqFLqHWXoW2" title="Derivative liability"&gt;1,361&lt;/span&gt;, compared to $&lt;span id="xdx_905_eus-gaap--DerivativeFairValueOfDerivativeLiability_iI_c20250831__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zCUKsAUQbke3" title="Derivative liability"&gt;1,386&lt;/span&gt; at issuance, resulting in a non-cash gain of $&lt;span id="xdx_903_ecustom--NonCashGain_iI_c20250831_zcaN536dFgM5" title="Non cash gain"&gt;25&lt;/span&gt; recognized in &#x201c;Change in fair value of derivative liability.&#x201d; Interest expense of approximately $&lt;span id="xdx_90C_eus-gaap--InterestExpense_c20241201__20251130__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zpdvsHSFIuR3" title="Interest expense"&gt;5,616&lt;/span&gt; was incurred and accrued for the year ended November 30, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The fair value of the conversion feature was estimated
at the as converted value at September 30, 2025 and initial measurement date of September 23, 2025 to be $&lt;span id="xdx_90E_ecustom--FairValueOfConversion_c20241201__20250930_zsdpg0x7r3ci" title="Fair value of the conversion"&gt;1,361&lt;/span&gt; and $&lt;span id="xdx_907_ecustom--FairValueOfConversion_c20241201__20250923_zuFBJKOUgyDl" title="Fair value of the conversion"&gt;1,386&lt;/span&gt;, respectively.
The binomial tree model was used based on the following key assumptions:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfFairValueOfTheConversionFeatureAssumptionsTableTextBlock_hus-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zXYeWJAqddYf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related Party Transactions (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8BB_z3RBsCyrQGW1" style="display: none"&gt;Schedule
    of fair value of the conversion feature assumptions&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;At Issuance &#x96;&lt;br/&gt;
September&#160;23,&lt;br/&gt;
2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;At&lt;br/&gt;
September&#160;30,&lt;br/&gt;
2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; width: 76%; vertical-align: top"&gt;Strike Price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--StrikePrice_iI_c20250923__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zaz5z0T301s4" style="width: 9%; text-align: right" title="Strike Price"&gt;1.88&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--StrikePrice_iI_c20250930__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zK3t5cHezgG7" style="width: 9%; text-align: right" title="Strike Price"&gt;1.88&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;Stock Price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--SaleOfStockPricePerShare_iI_c20250923__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zekx1jHu2vGh" style="text-align: right" title="Stock Price"&gt;1.88&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SaleOfStockPricePerShare_iI_c20250930__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_z0pc939QMEF1" style="text-align: right" title="Stock Price"&gt;1.88&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Time to maturity (in year)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20241201__20250923__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zwanwTvzEtu1" title="Time to maturity (in year)"&gt;0.52&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zgdDidpnDlH1" title="Time to maturity (in year)"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Business combination success rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--BusinessCombinationSuccessRate_dp_c20241201__20250923__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_z7SZhwum1xod" title="Business combination success rate"&gt;32.79&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--BusinessCombinationSuccessRate_dp_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zjyB9obtRIn3" title="Business combination success rate"&gt;32.79&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Expected Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20241201__20250923__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zwqHzX5yAkOf" title="Expected Volatility"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zO0zIvM1gZQi" title="Expected Volatility"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Expected dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20241201__20250923__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zI3SfIHazYva" title="Expected dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zcmQvYcZDLn6" title="Expected dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20241201__20250923__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zopAIF2KXYLf" title="Risk-free rate"&gt;3.61&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zTXDG6UXbpz8" title="Risk-free rate"&gt;3.68&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zmX9JLQxkjR" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table presents the changes in the
fair value of the Level 3 Derivative liability - Convertible Note conversion option:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_hus-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zX5ypGrqKpA" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related Party Transactions (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8BB_zc41J7a6ff6j" style="display: none"&gt;Schedule of Derivative Liabilities at fair value&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;Fair value as of November 30, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--LiabilitiesFairValueDisclosure_iS_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zSnX6fhZND2j" style="text-align: right" title="Change in fair value, beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0785"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left"&gt;Initial recognition at issuance (September 23, 2025)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--InitialRecognitionAtIssuance_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zulSvSktknQg" style="width: 9%; text-align: right" title="Initial recognition at issuance"&gt;1,386&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;Change in valuation recognized in earnings&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ChangeInValuationRecognizedInEarnings_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zq1nudTnwdt7" style="border-bottom: Black 1pt solid; text-align: right" title="Change in valuation recognized in earnings"&gt;(25&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt; vertical-align: top"&gt;Fair value as of September 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LiabilitiesFairValueDisclosure_iE_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zGCNV0tq5QTg" style="border-bottom: Black 2.5pt double; text-align: right" title="Change in fair value, ending"&gt;1,361&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_zOeQ9eiYlWx1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Related Party Loans&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In addition, in order to finance transaction costs in connection with an intended initial Business Combination, the Initial Shareholders or their affiliates may, but are not obligated to, loan us funds as may be required. If the Company completes an initial Business Combination, it will repay such loaned amounts. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from the Trust Account would be used for such repayment. Certain amount of such loans may be converted into private at $10.00 per share at the option of the lender. As of November&#160;30, 2025 and the Company had &lt;span id="xdx_90F_ecustom--WorkingCapitalLoans_iI_do_c20251130_zcMX0ov7wi1k" title="Working capital loans"&gt;&lt;span id="xdx_902_ecustom--WorkingCapitalLoans_iI_do_c20241130_zZTzFeDBlpb5" title="Working capital loans"&gt;no&lt;/span&gt;&lt;/span&gt; borrowings under the working capital loans.&lt;/p&gt;









&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Administrative Services Agreement&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company entered into an Administrative Services Agreement with the Sponsor on December&#160;4, 2023, commencing on the effective date of the registration statement of IPO through the later of the Company&#x2019;s consummation of a Business Combination or 21 months from such effective date, to pay the Sponsor a total of $&lt;span id="xdx_904_eus-gaap--OtherGeneralAndAdministrativeExpense_c20241201__20251130_zy19A3IX3oLc" title="General and administrative expenses"&gt;10,000 &lt;/span&gt;per month for office space and administrative and support services. The Company incurred and paid to the Sponsor $&lt;span id="xdx_900_eus-gaap--AdministrativeFeesExpense_pp0p0_c20241201__20251130_zXQZJnb4AJG5" title="Administrative expense paid to the Sponsor"&gt;120,000&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--AdministrativeFeesExpense_pp0p0_c20231201__20241130_zhVZ6dNLMlx8" title="Administrative expense paid to the Sponsor"&gt;83,945&lt;/span&gt; for the year ended November 30, 2025 and 2024, respectively; no amount was outstanding as of November&#160;30, 2025 and 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;



</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-10-012023-10-16_custom_SponsorMember"
      decimals="INF"
      id="Fact000644"
      unitRef="Shares">17250000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharePrice
      contextRef="AsOf2023-10-16_custom_SponsorMember_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000646"
      unitRef="USDPShares">0.0001</us-gaap:SharePrice>
    <BKHAU:AggregatedConsideration
      contextRef="From2023-10-012023-10-16_custom_FounderSharesMember"
      decimals="0"
      id="Fact000648"
      unitRef="USD">25000</BKHAU:AggregatedConsideration>
    <us-gaap:SharePrice
      contextRef="AsOf2023-10-16_custom_FounderSharesMember"
      decimals="INF"
      id="Fact000650"
      unitRef="USDPShares">0.0145</us-gaap:SharePrice>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2023-10-012023-10-16_custom_FounderSharesMember"
      decimals="INF"
      id="Fact000652"
      unitRef="Shares">17250000</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2023-10-012023-10-16_custom_FounderSharesMember_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000654"
      unitRef="Shares">1725000</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2024-03-012024-03-18_custom_FounderSharesMember_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000656"
      unitRef="Shares">1725000</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2024-03-012024-03-18_custom_FounderSharesMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000658"
      unitRef="Shares">1725000</us-gaap:ConversionOfStockSharesConverted1>
    <BKHAU:AdjustedClassBOrdinaryShares
      contextRef="From2024-03-012024-03-20"
      decimals="INF"
      id="Fact000660"
      unitRef="Shares">1983750</BKHAU:AdjustedClassBOrdinaryShares>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2024-03-20"
      decimals="INF"
      id="Fact000662"
      unitRef="USDPShares">0.0126</us-gaap:SaleOfStockPricePerShare>
    <BKHAU:FounderSharesIssued
      contextRef="AsOf2025-11-30"
      decimals="INF"
      id="Fact000664"
      unitRef="Shares">1725000</BKHAU:FounderSharesIssued>
    <BKHAU:FounderSharesOutstanding
      contextRef="AsOf2025-11-30"
      decimals="INF"
      id="Fact000666"
      unitRef="Shares">1725000</BKHAU:FounderSharesOutstanding>
    <BKHAU:FounderSharesIssued
      contextRef="AsOf2024-11-30"
      decimals="INF"
      id="Fact000668"
      unitRef="Shares">1725000</BKHAU:FounderSharesIssued>
    <BKHAU:FounderSharesOutstanding
      contextRef="AsOf2024-11-30"
      decimals="INF"
      id="Fact000670"
      unitRef="Shares">1725000</BKHAU:FounderSharesOutstanding>
    <us-gaap:ProfessionalFees
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000671"
      unitRef="USD">30900</us-gaap:ProfessionalFees>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-10-16"
      decimals="0"
      id="Fact000672"
      unitRef="USD">250000</us-gaap:DebtInstrumentFaceAmount>
    <BKHAU:ConvertiblePromissoryNotes contextRef="From2024-12-01to2025-11-30" id="Fact000674">each permitting borrowings of up to $350,000. As of November 30, 2025, the Company had drawn $350,000 under the June Note
and $250,000 under the September Note.</BKHAU:ConvertiblePromissoryNotes>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000678"
      unitRef="USD">4538</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000680"
      unitRef="USD">15454</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <BKHAU:DebtDiscount
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000682"
      unitRef="USD">3244</BKHAU:DebtDiscount>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="Fact000684"
      unitRef="USD">3177</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="AsOf2025-08-31"
      decimals="0"
      id="Fact000686"
      unitRef="USD">3244</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <BKHAU:NonCashLoss
      contextRef="AsOf2025-08-31"
      decimals="0"
      id="Fact000688"
      unitRef="USD">67</BKHAU:NonCashLoss>
    <us-gaap:InterestExpense
      contextRef="From2024-12-012025-11-30_custom_JuneConvertibleNoteMember"
      decimals="0"
      id="Fact000690"
      unitRef="USD">9838</us-gaap:InterestExpense>
    <BKHAU:FairValueOfConversion
      contextRef="From2024-12-012025-09-30_custom_ConvertibleNoteMember"
      decimals="0"
      id="Fact000692"
      unitRef="USD">3177</BKHAU:FairValueOfConversion>
    <BKHAU:FairValueOfConversion
      contextRef="From2024-12-012025-06-13_custom_ConvertibleNoteMember"
      decimals="0"
      id="Fact000694"
      unitRef="USD">3244</BKHAU:FairValueOfConversion>
    <BKHAU:ScheduleOfFairValueOfTheConversionFeatureAssumptionsTableTextBlock
      contextRef="From2024-12-012025-11-30_custom_ConvertibleNoteMember"
      id="Fact000696">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfFairValueOfTheConversionFeatureAssumptionsTableTextBlock_hus-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zWMkNdZe3gkd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related Party Transactions (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&lt;span id="xdx_8B6_zVkgODueIZD2" style="display: none"&gt;Schedule
    of fair value of the conversion feature assumptions&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;At Issuance &#x96;&lt;br/&gt;
June&#160;13,&lt;br/&gt;
2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;At&lt;br/&gt;
September&#160;30,&lt;br/&gt;
2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; width: 76%; vertical-align: top"&gt;Strike Price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--StrikePrice_iI_c20250613__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zc7mcXvVdsJb" style="width: 9%; text-align: right" title="Strike Price"&gt;1.88&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--StrikePrice_iI_c20250930__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zHlx01zjPdsd" style="width: 9%; text-align: right" title="Strike Price"&gt;1.88&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;Stock Price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SaleOfStockPricePerShare_iI_c20250613__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zb9DRY563oR3" style="text-align: right" title="Stock Price"&gt;1.88&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SaleOfStockPricePerShare_iI_c20250930__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_znJlGh6IV6b" style="text-align: right" title="Stock Price"&gt;1.88&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Time to maturity (in year)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20241201__20250613__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_z3mbUSbhuwTg" title="Time to maturity (in year)"&gt;0.53&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_z151opfBOMeb" title="Time to maturity (in year)"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Business combination success rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--BusinessCombinationSuccessRate_dp_c20241201__20250613__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zw5dyJt6Ev67" title="Business combination success rate"&gt;32.14&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--BusinessCombinationSuccessRate_dp_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zNGtQUSUrcie" title="Business combination success rate"&gt;32.79&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Expected Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20241201__20250613__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zurh5DhxrWA" title="Expected Volatility"&gt;5.7&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zkLZEIQ1VCcd" title="Expected Volatility"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Expected dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20241201__20250613__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zEzrXDFLyEhl" title="Expected dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zrVTkEwlUBih" title="Expected dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20241201__20250613__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_z0kuNhqiFYLk" title="Risk-free rate"&gt;4.02&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zLSojALL7s7f" title="Risk-free rate"&gt;3.68&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</BKHAU:ScheduleOfFairValueOfTheConversionFeatureAssumptionsTableTextBlock>
    <BKHAU:StrikePrice
      contextRef="AsOf2025-06-13_custom_ConvertibleNoteMember"
      decimals="INF"
      id="Fact000698"
      unitRef="USDPShares">1.88</BKHAU:StrikePrice>
    <BKHAU:StrikePrice
      contextRef="AsOf2025-09-30_custom_ConvertibleNoteMember"
      decimals="INF"
      id="Fact000700"
      unitRef="USDPShares">1.88</BKHAU:StrikePrice>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2025-06-13_custom_ConvertibleNoteMember"
      decimals="INF"
      id="Fact000702"
      unitRef="USDPShares">1.88</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2025-09-30_custom_ConvertibleNoteMember"
      decimals="INF"
      id="Fact000704"
      unitRef="USDPShares">1.88</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-12-012025-06-13_custom_ConvertibleNoteMember"
      id="Fact000706">P0Y6M10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-12-012025-09-30_custom_ConvertibleNoteMember"
      id="Fact000708">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <BKHAU:BusinessCombinationSuccessRate
      contextRef="From2024-12-012025-06-13_custom_ConvertibleNoteMember"
      decimals="INF"
      id="Fact000710"
      unitRef="Pure">0.3214</BKHAU:BusinessCombinationSuccessRate>
    <BKHAU:BusinessCombinationSuccessRate
      contextRef="From2024-12-012025-09-30_custom_ConvertibleNoteMember"
      decimals="INF"
      id="Fact000712"
      unitRef="Pure">0.3279</BKHAU:BusinessCombinationSuccessRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-12-012025-06-13_custom_ConvertibleNoteMember"
      decimals="INF"
      id="Fact000714"
      unitRef="Pure">0.057</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-12-012025-09-30_custom_ConvertibleNoteMember"
      decimals="INF"
      id="Fact000716"
      unitRef="Pure">0.061</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2024-12-012025-06-13_custom_ConvertibleNoteMember"
      decimals="INF"
      id="Fact000718"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2024-12-012025-09-30_custom_ConvertibleNoteMember"
      decimals="INF"
      id="Fact000720"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2024-12-012025-06-13_custom_ConvertibleNoteMember"
      decimals="INF"
      id="Fact000722"
      unitRef="Pure">0.0402</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2024-12-012025-09-30_custom_ConvertibleNoteMember"
      decimals="INF"
      id="Fact000724"
      unitRef="Pure">0.0368</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock
      contextRef="From2024-12-012025-11-30_custom_ConvertibleNoteMember"
      id="Fact000727">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_hus-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_z6l6eJ91Jizj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related Party Transactions (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8BE_zJfhjfE4CVF3" style="display: none"&gt;Schedule of Derivative Liabilities at fair value&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;Fair value as of November 30, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iS_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zjI7XoVMC1x2" style="text-align: right" title="Change in fair value, beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0729"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left"&gt;Initial recognition at issuance (June 13, 2025)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--InitialRecognitionAtIssuance_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zVrHydvd3rYh" style="width: 9%; text-align: right" title="Initial recognition at issuance"&gt;3,244&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;Change in valuation recognized in earnings&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ChangeInValuationRecognizedInEarnings_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_z34PcGLPH473" style="border-bottom: Black 1pt solid; text-align: right" title="Change in valuation recognized in earnings"&gt;(67&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt; vertical-align: top"&gt;Fair value as of September 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LiabilitiesFairValueDisclosure_iE_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNoteMember_zBpl8OdL0YM1" style="border-bottom: Black 2.5pt double; text-align: right" title="Change in fair value, ending"&gt;3,177&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock>
    <BKHAU:InitialRecognitionAtIssuance
      contextRef="From2024-12-012025-09-30_custom_ConvertibleNoteMember"
      decimals="0"
      id="Fact000731"
      unitRef="USD">3244</BKHAU:InitialRecognitionAtIssuance>
    <BKHAU:ChangeInValuationRecognizedInEarnings
      contextRef="From2024-12-012025-09-30_custom_ConvertibleNoteMember"
      decimals="0"
      id="Fact000733"
      unitRef="USD">-67</BKHAU:ChangeInValuationRecognizedInEarnings>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2025-09-30_custom_ConvertibleNoteMember"
      decimals="0"
      id="Fact000735"
      unitRef="USD">3177</us-gaap:LiabilitiesFairValueDisclosure>
    <BKHAU:DebtDiscount
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="Fact000737"
      unitRef="USD">1387</BKHAU:DebtDiscount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="Fact000739"
      unitRef="USD">150000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="AsOf2025-09-30_custom_ConvertibleNoteMember"
      decimals="0"
      id="Fact000741"
      unitRef="USD">1361</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="AsOf2025-08-31_custom_ConvertibleNoteMember"
      decimals="0"
      id="Fact000743"
      unitRef="USD">1386</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <BKHAU:NonCashGain
      contextRef="AsOf2025-08-31"
      decimals="0"
      id="Fact000745"
      unitRef="USD">25</BKHAU:NonCashGain>
    <us-gaap:InterestExpense
      contextRef="From2024-12-012025-11-30_custom_ConvertibleNoteMember"
      decimals="0"
      id="Fact000747"
      unitRef="USD">5616</us-gaap:InterestExpense>
    <BKHAU:FairValueOfConversion
      contextRef="From2024-12-012025-09-30"
      decimals="0"
      id="Fact000749"
      unitRef="USD">1361</BKHAU:FairValueOfConversion>
    <BKHAU:FairValueOfConversion
      contextRef="From2024-12-012025-09-23"
      decimals="0"
      id="Fact000751"
      unitRef="USD">1386</BKHAU:FairValueOfConversion>
    <BKHAU:ScheduleOfFairValueOfTheConversionFeatureAssumptionsTableTextBlock
      contextRef="From2024-12-012025-11-30_custom_SeptemberConvertibleNoteMember"
      id="Fact000753">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfFairValueOfTheConversionFeatureAssumptionsTableTextBlock_hus-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zXYeWJAqddYf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related Party Transactions (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8BB_z3RBsCyrQGW1" style="display: none"&gt;Schedule
    of fair value of the conversion feature assumptions&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;At Issuance &#x96;&lt;br/&gt;
September&#160;23,&lt;br/&gt;
2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;At&lt;br/&gt;
September&#160;30,&lt;br/&gt;
2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; width: 76%; vertical-align: top"&gt;Strike Price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--StrikePrice_iI_c20250923__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zaz5z0T301s4" style="width: 9%; text-align: right" title="Strike Price"&gt;1.88&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--StrikePrice_iI_c20250930__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zK3t5cHezgG7" style="width: 9%; text-align: right" title="Strike Price"&gt;1.88&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;Stock Price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--SaleOfStockPricePerShare_iI_c20250923__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zekx1jHu2vGh" style="text-align: right" title="Stock Price"&gt;1.88&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SaleOfStockPricePerShare_iI_c20250930__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_z0pc939QMEF1" style="text-align: right" title="Stock Price"&gt;1.88&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Time to maturity (in year)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20241201__20250923__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zwanwTvzEtu1" title="Time to maturity (in year)"&gt;0.52&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zgdDidpnDlH1" title="Time to maturity (in year)"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Business combination success rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--BusinessCombinationSuccessRate_dp_c20241201__20250923__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_z7SZhwum1xod" title="Business combination success rate"&gt;32.79&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--BusinessCombinationSuccessRate_dp_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zjyB9obtRIn3" title="Business combination success rate"&gt;32.79&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Expected Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20241201__20250923__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zwqHzX5yAkOf" title="Expected Volatility"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zO0zIvM1gZQi" title="Expected Volatility"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Expected dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20241201__20250923__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zI3SfIHazYva" title="Expected dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zcmQvYcZDLn6" title="Expected dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20241201__20250923__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zopAIF2KXYLf" title="Risk-free rate"&gt;3.61&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zTXDG6UXbpz8" title="Risk-free rate"&gt;3.68&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</BKHAU:ScheduleOfFairValueOfTheConversionFeatureAssumptionsTableTextBlock>
    <BKHAU:StrikePrice
      contextRef="AsOf2025-09-23_custom_SeptemberConvertibleNoteMember"
      decimals="INF"
      id="Fact000755"
      unitRef="USDPShares">1.88</BKHAU:StrikePrice>
    <BKHAU:StrikePrice
      contextRef="AsOf2025-09-30_custom_SeptemberConvertibleNoteMember"
      decimals="INF"
      id="Fact000757"
      unitRef="USDPShares">1.88</BKHAU:StrikePrice>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2025-09-23_custom_SeptemberConvertibleNoteMember"
      decimals="INF"
      id="Fact000759"
      unitRef="USDPShares">1.88</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2025-09-30_custom_SeptemberConvertibleNoteMember"
      decimals="INF"
      id="Fact000761"
      unitRef="USDPShares">1.88</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-12-012025-09-23_custom_SeptemberConvertibleNoteMember"
      id="Fact000763">P0Y6M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-12-012025-09-30_custom_SeptemberConvertibleNoteMember"
      id="Fact000765">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <BKHAU:BusinessCombinationSuccessRate
      contextRef="From2024-12-012025-09-23_custom_SeptemberConvertibleNoteMember"
      decimals="INF"
      id="Fact000767"
      unitRef="Pure">0.3279</BKHAU:BusinessCombinationSuccessRate>
    <BKHAU:BusinessCombinationSuccessRate
      contextRef="From2024-12-012025-09-30_custom_SeptemberConvertibleNoteMember"
      decimals="INF"
      id="Fact000769"
      unitRef="Pure">0.3279</BKHAU:BusinessCombinationSuccessRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-12-012025-09-23_custom_SeptemberConvertibleNoteMember"
      decimals="INF"
      id="Fact000771"
      unitRef="Pure">0.061</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-12-012025-09-30_custom_SeptemberConvertibleNoteMember"
      decimals="INF"
      id="Fact000773"
      unitRef="Pure">0.061</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2024-12-012025-09-23_custom_SeptemberConvertibleNoteMember"
      decimals="INF"
      id="Fact000775"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2024-12-012025-09-30_custom_SeptemberConvertibleNoteMember"
      decimals="INF"
      id="Fact000777"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2024-12-012025-09-23_custom_SeptemberConvertibleNoteMember"
      decimals="INF"
      id="Fact000779"
      unitRef="Pure">0.0361</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2024-12-012025-09-30_custom_SeptemberConvertibleNoteMember"
      decimals="INF"
      id="Fact000781"
      unitRef="Pure">0.0368</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock
      contextRef="From2024-12-012025-11-30_custom_SeptemberConvertibleNoteMember"
      id="Fact000783">&lt;table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_hus-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zX5ypGrqKpA" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related Party Transactions (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8BB_zc41J7a6ff6j" style="display: none"&gt;Schedule of Derivative Liabilities at fair value&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;Fair value as of November 30, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--LiabilitiesFairValueDisclosure_iS_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zSnX6fhZND2j" style="text-align: right" title="Change in fair value, beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0785"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left"&gt;Initial recognition at issuance (September 23, 2025)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--InitialRecognitionAtIssuance_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zulSvSktknQg" style="width: 9%; text-align: right" title="Initial recognition at issuance"&gt;1,386&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;Change in valuation recognized in earnings&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ChangeInValuationRecognizedInEarnings_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zq1nudTnwdt7" style="border-bottom: Black 1pt solid; text-align: right" title="Change in valuation recognized in earnings"&gt;(25&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt; vertical-align: top"&gt;Fair value as of September 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LiabilitiesFairValueDisclosure_iE_c20241201__20250930__us-gaap--ShortTermDebtTypeAxis__custom--SeptemberConvertibleNoteMember_zGCNV0tq5QTg" style="border-bottom: Black 2.5pt double; text-align: right" title="Change in fair value, ending"&gt;1,361&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock>
    <BKHAU:InitialRecognitionAtIssuance
      contextRef="From2024-12-012025-09-30_custom_SeptemberConvertibleNoteMember"
      decimals="0"
      id="Fact000787"
      unitRef="USD">1386</BKHAU:InitialRecognitionAtIssuance>
    <BKHAU:ChangeInValuationRecognizedInEarnings
      contextRef="From2024-12-012025-09-30_custom_SeptemberConvertibleNoteMember"
      decimals="0"
      id="Fact000789"
      unitRef="USD">-25</BKHAU:ChangeInValuationRecognizedInEarnings>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2025-09-30_custom_SeptemberConvertibleNoteMember"
      decimals="0"
      id="Fact000791"
      unitRef="USD">1361</us-gaap:LiabilitiesFairValueDisclosure>
    <BKHAU:WorkingCapitalLoans
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000793"
      unitRef="USD">0</BKHAU:WorkingCapitalLoans>
    <BKHAU:WorkingCapitalLoans
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000795"
      unitRef="USD">0</BKHAU:WorkingCapitalLoans>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000799"
      unitRef="USD">10000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:AdministrativeFeesExpense
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000801"
      unitRef="USD">120000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000803"
      unitRef="USD">83945</us-gaap:AdministrativeFeesExpense>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2024-12-01to2025-11-30" id="Fact000805">&lt;p id="xdx_809_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zgQzlxWA538l" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 6 &#x2014; &lt;span id="xdx_824_zfw5MCTTXN5d"&gt;Commitments and Contingencies&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Registration Rights&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The holders of the Founder Shares issued and outstanding on the date of this prospectus, as well as the holders of the private units and any shares of the Company&#x2019;s insiders, officers, directors or their affiliates may be issued in payment of working capital loans and extension loans made to the Company (and any shares of ordinary shares issuable upon conversion of the underlying the private rights), will be entitled to registration rights pursuant to an agreement to be signed prior to or on the effective date of the registration statement. The holders of a majority of these securities are entitled to make up to two demands that we register such securities. The holders of the majority of the Founder Shares can elect to exercise these registration rights at any time commencing three months prior to the date on which these shares of ordinary shares are to be released from trust. The holders of a majority of the private units and units issued in payment of working capital loans made to us can elect to exercise these registration rights at any time commencing on the date that the Company consummate an initial business combination. In addition, the holders have certain &#x201c;piggy-back&#x201d; registration rights with respect to registration statements filed subsequent to the consummation of an initial business combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Right of First Refusal&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has granted EF Hutton for a period of 18 months after the date of the consummation of the Company&#x2019;s Business Combination, an irrevocable right of first refusal to act as lead left book-running managing underwriter or lead left placement agent with at least 50% of the economics; or, in the case of a three-handed deal, 40% of the economics, for any and all future public and private equity, convertible and debt offerings.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Underwriting Agreement&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company granted EF Hutton, the representative of the underwriters, a 45-day option from March&#160;22, 2024, to purchase up to &lt;span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20241201__20251130_zwBX9qEhJvV7" title="Sale of units in initial public offering"&gt;1,035,000&lt;/span&gt; additional Units to cover over-allotments, if any, at the IPO price less the underwriting discounts and commissions. The over-allotment option is deemed to be a freestanding financial instrument indexed on the contingently redeemable shares and is accounted for as a liability pursuant to ASC 480. The value of the over-allotment option was estimated to be $&lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_c20240301__20240322__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zBpBRMcD97o6" title="Option exercised"&gt;93,150&lt;/span&gt; as of March&#160;22, 2024. The underwriters did not excise the over-allotment option, as such, there was &lt;span id="xdx_904_eus-gaap--AccruedLiabilitiesCurrent_iI_pp0p0_do_c20251130_zwrUKYnYrCL2" title="Accrued liability"&gt;no&lt;/span&gt; liability accrued on the balance sheet as of November&#160;30, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The underwriters were paid a cash underwriting discount of 1.0% of the gross proceeds of the IPO or $&lt;span id="xdx_90C_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20241201__20251130__us-gaap--SubsidiarySaleOfStockAxis__custom--ProposedPublicOfferingMember_zKwpJ4RF8dB6" title="Gross proceeds from proposed Public Offering"&gt;690,000&lt;/span&gt;. In addition, the underwriters will be entitled to a deferred fee of 3.5% of the gross proceeds of the IPO or $&lt;span id="xdx_909_ecustom--GrossProceedsFromInitialPublicOffering_pp0p0_c20241201__20251130_zuRIRDzRACp6" title="Gross proceeds from Initial Public Offering"&gt;2,415,000&lt;/span&gt; will be paid upon the closing of a Business Combination from the amounts held in the Trust Account, subject to the terms of the underwriting agreement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Additionally, the Company issued the underwriters &lt;span id="xdx_90E_eus-gaap--SharesIssued_iI_c20240322__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zDHPlYnk6jvd" title="Additional shares issued"&gt;69,000&lt;/span&gt; shares of Class A ordinary shares for the representative shares, at the closing of the IPO as part of representative compensation on March&#160;22, 2024.&lt;/p&gt;











</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-12-01to2025-11-30"
      decimals="INF"
      id="Fact000807"
      unitRef="Shares">1035000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2024-03-012024-03-22_us-gaap_OverAllotmentOptionMember"
      decimals="0"
      id="Fact000809"
      unitRef="USD">93150</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000811"
      unitRef="USD">0</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2024-12-012025-11-30_custom_ProposedPublicOfferingMember"
      decimals="0"
      id="Fact000813"
      unitRef="USD">690000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <BKHAU:GrossProceedsFromInitialPublicOffering
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000815"
      unitRef="USD">2415000</BKHAU:GrossProceedsFromInitialPublicOffering>
    <us-gaap:SharesIssued
      contextRef="AsOf2024-03-22_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000817"
      unitRef="Shares">69000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2024-12-01to2025-11-30" id="Fact000821">&lt;p id="xdx_804_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z7ZdI2F7Ufvb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 7 &#x2014; &lt;span id="xdx_82F_ztPwd5qGuk93"&gt;Shareholders&#x2019; Deficit&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Ordinary Shares&lt;/i&gt;&lt;/b&gt; &#x2014; The Company is authorized to issue up to &lt;span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20251130__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zRudyjJxJdt7"&gt;450,000,000&lt;/span&gt; Class A ordinary shares and &lt;span id="xdx_909_eus-gaap--CommonStockSharesAuthorized_iI_c20251130__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zEjBldNEnux5"&gt;50,000,000&lt;/span&gt; Class B ordinary shares, par value $&lt;span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20251130__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zPH2Ul9Etrd8"&gt;0.0001&lt;/span&gt; per share. Holders of Class A ordinary shares and holders of Class B ordinary shares are entitled to one vote for each share held on all matters to be voted on by the shareholders, except as required by law; provided that, prior to the initial Business Combination, only holders of our Class B ordinary shares will have the right to vote on the appointment of directors, and holders of a majority of the Class B ordinary shares may remove a member of the board of directors. With respect to any other matter submitted to a vote of the Company&#x2019;s shareholders, including any vote in connection with the initial Business Combination, except as required by law or the Company&#x2019;s articles of association, holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class. The Class B ordinary shares held by the Sponsor may convert into Class A ordinary shares at any time at their option, but will automatically convert into Class A ordinary shares upon the completion of the initial Business Combination on a one-for-one basis, subject to adjustments. On March&#160;18, 2024, the Company elected to convert &lt;span id="xdx_909_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20240318__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zaVnid5U0Thf"&gt;1,725,000&lt;/span&gt; Class B ordinary shares into &lt;span id="xdx_902_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20240318__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zLJFISoEIen6"&gt;1,725,000&lt;/span&gt; Class A ordinary shares upon the closing of IPO. On March&#160;20, 2024, the Company and the Sponsor entered into the Second Amendment to the Subscription Agreement, pursuant to which the purchased amount of shares was adjusted to &lt;span id="xdx_901_ecustom--AdjustedClassBOrdinaryShares_c20240301__20240320_zJDaGrYVKUc3" title="Adjusted class B ordinary shares"&gt;1,983,750&lt;/span&gt; Class B ordinary shares, $&lt;span id="xdx_909_eus-gaap--SaleOfStockPricePerShare_iI_c20240320_zGOY49IjINrg"&gt;0.0126&lt;/span&gt; par value per ordinary share. As of November&#160;30, 2025 and 2024, there were &lt;span id="xdx_90B_eus-gaap--CommonStockSharesOutstanding_iI_c20251130__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zMFcaElzWnO8"&gt;2,029,500&lt;/span&gt; Class A non-redeemable ordinary shares issued and outstanding (excluding 2,124,077 and 6,900,000 Class A ordinary shares subject to redemption as of November&#160;30, 2025 and November&#160;30, 2024, respectively).&lt;/p&gt;

&lt;p style="margin: 0; font-size: 10pt"&gt;&#160;&lt;/p&gt;

&lt;p style="margin: 0; font-size: 10pt; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Rights &lt;/i&gt;&lt;/b&gt;&#x2014; Each holder of a right will receive one share of Class A Ordinary Share upon consummation of a Business Combination, even if the holder of such right redeemed all shares held by it in connection with a Business Combination. No fractional shares will be issued upon conversion of the rights. No additional consideration will be required to be paid by a holder of rights in order to receive its additional shares upon consummation of a Business Combination, as the consideration related thereto has been included in the Unit purchase price paid for by investors in the IPO. If the Company enters into a definitive agreement for a Business Combination in which the Company will not be the surviving entity, the definitive agreement will provide for the holders of rights to receive the same per share consideration the holders of the common stock will receive in the transaction on an as-converted into common stock basis and each holder of a right will be required to affirmatively covert its rights in order to receive one share underlying each right (without paying additional consideration). The shares issuable upon conversion of the rights will be freely tradable (except to the extent held by affiliates of the Company).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of rights will not receive any of such funds with respect to their rights, nor will they receive any distribution from the Company&#x2019;s assets held outside of the Trust Account with respect to such rights, and the rights will expire worthless. Further, there are no contractual penalties for failure to deliver securities to the holders of the rights upon consummation of a Business Combination. Additionally, in no event will the Company be required to net cash settle the rights. Accordingly, holders of the rights might not receive the shares of common stock underlying the rights.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-11-30_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000822"
      unitRef="Shares">450000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-11-30_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000823"
      unitRef="Shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-11-30_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000824"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2024-03-012024-03-18_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000825"
      unitRef="Shares">1725000</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2024-03-012024-03-18_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000826"
      unitRef="Shares">1725000</us-gaap:ConversionOfStockSharesConverted1>
    <BKHAU:AdjustedClassBOrdinaryShares
      contextRef="From2024-03-012024-03-20"
      decimals="INF"
      id="Fact000828"
      unitRef="Shares">1983750</BKHAU:AdjustedClassBOrdinaryShares>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2024-03-20"
      decimals="INF"
      id="Fact000829"
      unitRef="USDPShares">0.0126</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-11-30_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact000830"
      unitRef="Shares">2029500</us-gaap:CommonStockSharesOutstanding>
    <BKHAU:DueToTargetCompanyTextBlock contextRef="From2024-12-01to2025-11-30" id="Fact000832">&lt;p id="xdx_804_ecustom--DueToTargetCompanyTextBlock_z2iq8G644MU7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note 8 &#x2014; &lt;span id="xdx_82D_z3SxobqmLPI3"&gt;Due to Target Company&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In connection with the Extension, the
Vesicor agreed to contribute half the Extension Payment. For the year ended November 2025 and 2024, Vesicor contributed $&lt;span id="xdx_90E_ecustom--DueToTargetCompany_iI_c20251130_ziuN4is6mxnf" title="Due to target company"&gt;575,000&lt;/span&gt;
and $&lt;span id="xdx_906_ecustom--DueToTargetCompany_iI_c20241130_z2wkEPbNS498" title="Due to target company"&gt;0&lt;/span&gt;,
respectively. The amount provided is interest free and will be reimbursed by the surviving company&#x2019;s common stock upon closing
of the business combination. The loan can be converted at $9.40 per share. If, 180 days after closing, the company&#x2019;s common stock is trading at $5.00 or lower,
the reimbursement rate will increase to $5.00 per share, with additional ordinary shares issued to compensate the Target for the monetary
value paid.&lt;/p&gt;












</BKHAU:DueToTargetCompanyTextBlock>
    <BKHAU:DueToTargetCompany
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000834"
      unitRef="USD">575000</BKHAU:DueToTargetCompany>
    <BKHAU:DueToTargetCompany
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000836"
      unitRef="USD">0</BKHAU:DueToTargetCompany>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="From2024-12-01to2025-11-30" id="Fact000840">&lt;p id="xdx_80D_eus-gaap--FairValueDisclosuresTextBlock_zqEoXE8u8Zn1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 9 &#x2014; &lt;span id="xdx_827_z4InJ0l0oage"&gt;Fair Value Measurements&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The fair value of the Company&#x2019;s financial assets and liabilities reflects management&#x2019;s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 0.25in; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 0.75in; text-align: justify"&gt;Level 1:&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: middle; text-align: justify; vertical-align: middle"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: justify; vertical-align: middle"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: justify; vertical-align: middle"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;Level 2:&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: middle; text-align: justify; vertical-align: middle"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: justify; vertical-align: middle"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: justify; vertical-align: middle"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;Level 3:&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table presents information about the Company&#x2019;s assets that are measured at fair value on a recurring basis as of November 30, 2025 and 2024, and indicate the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zg8CmTEhIJ2k" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Fair Value Measurements (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span id="xdx_8B2_zR1SPqO82Qnh" style="display: none"&gt;Schedule of Assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;November&#160;30,&lt;br/&gt;2025&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Quoted&lt;br/&gt;Prices in&lt;br/&gt;Active Markets&lt;br/&gt;(Level 1)&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; font-weight: bold; text-align: left"&gt;Assets&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 52%; text-align: left"&gt;Investments held in Trust Account&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20251130__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zFKcvtgqTyZ1" style="width: 9%; text-align: right" title="Cash held in Trust Account"&gt;23,827,149&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20251130__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zvec6fn0TkVf" style="width: 9%; text-align: right" title="Cash held in Trust Account"&gt;23,827,149&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20251130__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zvPwJBcaVCBd" style="width: 9%; text-align: right" title="Cash held in Trust Account"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0848"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20251130__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zBFKEykXq59f" style="width: 9%; text-align: right" title="Cash held in Trust Account"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0850"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Fair Value Measurements (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;November&#160;30,&lt;br/&gt; 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Quoted&lt;br/&gt; Prices in&lt;br/&gt; Active Markets&lt;br/&gt; (Level 1)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Significant&lt;br/&gt; Other&lt;br/&gt; Observable&lt;br/&gt; Inputs&lt;br/&gt; (Level 2)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Significant&lt;br/&gt; Other&lt;br/&gt; Unobservable&lt;br/&gt; Inputs&lt;br/&gt; (Level 3)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 52%"&gt;&lt;span style="font-size: 10pt"&gt;Investments held in Trust Account&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20241130__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zyCAvmArsrf7" style="vertical-align: bottom; width: 9%; text-align: right" title="Cash held in Trust Account"&gt;&lt;span style="font-size: 10pt"&gt;71,829,264&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20241130__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zMJZzp6Vm44d" style="vertical-align: bottom; width: 9%; text-align: right" title="Cash held in Trust Account"&gt;&lt;span style="font-size: 10pt"&gt;71,829,264&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20241130__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z7e68rSs5hp3" style="vertical-align: bottom; width: 9%; text-align: right" title="Cash held in Trust Account"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0856"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20241130__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z0QV5DPCpQFd" style="vertical-align: bottom; width: 9%; text-align: right" title="Cash held in Trust Account"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0858"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_zkhPT8MOG7re" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;














</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock contextRef="From2024-12-01to2025-11-30" id="Fact000842">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zg8CmTEhIJ2k" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Fair Value Measurements (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span id="xdx_8B2_zR1SPqO82Qnh" style="display: none"&gt;Schedule of Assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;November&#160;30,&lt;br/&gt;2025&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Quoted&lt;br/&gt;Prices in&lt;br/&gt;Active Markets&lt;br/&gt;(Level 1)&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; font-weight: bold; text-align: left"&gt;Assets&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 52%; text-align: left"&gt;Investments held in Trust Account&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20251130__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zFKcvtgqTyZ1" style="width: 9%; text-align: right" title="Cash held in Trust Account"&gt;23,827,149&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20251130__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zvec6fn0TkVf" style="width: 9%; text-align: right" title="Cash held in Trust Account"&gt;23,827,149&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20251130__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zvPwJBcaVCBd" style="width: 9%; text-align: right" title="Cash held in Trust Account"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0848"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20251130__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zBFKEykXq59f" style="width: 9%; text-align: right" title="Cash held in Trust Account"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0850"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Fair Value Measurements (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;November&#160;30,&lt;br/&gt; 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Quoted&lt;br/&gt; Prices in&lt;br/&gt; Active Markets&lt;br/&gt; (Level 1)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Significant&lt;br/&gt; Other&lt;br/&gt; Observable&lt;br/&gt; Inputs&lt;br/&gt; (Level 2)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Significant&lt;br/&gt; Other&lt;br/&gt; Unobservable&lt;br/&gt; Inputs&lt;br/&gt; (Level 3)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 52%"&gt;&lt;span style="font-size: 10pt"&gt;Investments held in Trust Account&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20241130__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zyCAvmArsrf7" style="vertical-align: bottom; width: 9%; text-align: right" title="Cash held in Trust Account"&gt;&lt;span style="font-size: 10pt"&gt;71,829,264&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20241130__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zMJZzp6Vm44d" style="vertical-align: bottom; width: 9%; text-align: right" title="Cash held in Trust Account"&gt;&lt;span style="font-size: 10pt"&gt;71,829,264&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20241130__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z7e68rSs5hp3" style="vertical-align: bottom; width: 9%; text-align: right" title="Cash held in Trust Account"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0856"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20241130__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z0QV5DPCpQFd" style="vertical-align: bottom; width: 9%; text-align: right" title="Cash held in Trust Account"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0858"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2025-11-30_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="0"
      id="Fact000844"
      unitRef="USD">23827149</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2025-11-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="0"
      id="Fact000846"
      unitRef="USD">23827149</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-11-30_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="0"
      id="Fact000852"
      unitRef="USD">71829264</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-11-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="0"
      id="Fact000854"
      unitRef="USD">71829264</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2024-12-01to2025-11-30" id="Fact000861">&lt;p id="xdx_805_eus-gaap--SegmentReportingDisclosureTextBlock_zQRaYOhxfIul" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note 10 &#x2014;&#160;&lt;span id="xdx_820_zgdFiJp17Nsc"&gt;Segment Information&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASC Topic 280, &#x201c;Segment Reporting,&#x201d; establishes standards for companies to report in their financial statement information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by the Company&#x2019;s chief operating decision maker, or group, in deciding how to allocate resources and assess performance.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s chief operating decision
maker has been identified as the Chief Executive Officer (&#x201c;CODM&#x201d;), who reviews the operating results for the Company as
a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined
that the Company only has&#160;one&#160;operating and reportable segment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The CODM assesses performance for the single
segment and decides how to allocate resources. The measure of segment assets is reported on the balance sheet as total assets. When evaluating
the Company&#x2019;s performance and making key decisions regarding resource allocation the CODM reviews several key metrics, which include
the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zeU1BvyGFyI6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Segment Information (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8B4_zW8giVOoy2Ik" style="display: none"&gt;Schedule of segment information&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20241201__20251130_zUoyonNKUv3h" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20231201__20241130_zSjdJm49nRxh" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;For&#160;the&lt;br/&gt; Year Ended&lt;br/&gt; November&#160;30,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--GeneralAndAdministrativeExpenses_z5uOFJUrkNrg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"&gt;General and administrative expenses&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;795,510&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;492,131&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--InterestIncomeExpenseNet_zXlU2WkKwqK5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Interest earned on investments held in Trust Account&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,258,631&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,484,264&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zosLnfCLsMF4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The key measures of segment profit or loss reviewed by the CODM are general and administrative expenses and interest earned on investments held in Trust Account. General and administrative expenses are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination within the business combination period. The CODM also reviews general and administrative expenses to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. Interest earned on investments held in Trust Account are reviewed to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the trust agreement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;




</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="From2024-12-01to2025-11-30" id="Fact000863">&lt;table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zeU1BvyGFyI6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Segment Information (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8B4_zW8giVOoy2Ik" style="display: none"&gt;Schedule of segment information&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20241201__20251130_zUoyonNKUv3h" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20231201__20241130_zSjdJm49nRxh" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;For&#160;the&lt;br/&gt; Year Ended&lt;br/&gt; November&#160;30,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--GeneralAndAdministrativeExpenses_z5uOFJUrkNrg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"&gt;General and administrative expenses&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;795,510&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;492,131&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--InterestIncomeExpenseNet_zXlU2WkKwqK5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Interest earned on investments held in Trust Account&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,258,631&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,484,264&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <BKHAU:GeneralAndAdministrativeExpenses
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000865"
      unitRef="USD">795510</BKHAU:GeneralAndAdministrativeExpenses>
    <BKHAU:GeneralAndAdministrativeExpenses
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000866"
      unitRef="USD">492131</BKHAU:GeneralAndAdministrativeExpenses>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="From2024-12-01to2025-11-30"
      decimals="0"
      id="Fact000868"
      unitRef="USD">2258631</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="From2023-12-012024-11-30"
      decimals="0"
      id="Fact000869"
      unitRef="USD">2484264</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2024-12-01to2025-11-30" id="Fact000871">&lt;p id="xdx_800_eus-gaap--SubsequentEventsTextBlock_zgCr7ozLO3H2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 11 &#x2014; &lt;span id="xdx_82B_zSQOcrcCMPl2"&gt;Subsequent Events&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company evaluated subsequent events and transactions that occurred after the balance sheet date up the date that the financial statement
was issued. Based on the review as further disclosed in the footnotes, management identified the following subsequent event requiring
disclosure in the financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In December 2025, the Company drew the remaining balance of the September
Convertible Note, totaling $&lt;span id="xdx_90B_ecustom--CompanyDrew_iI_c20251231_zM4ektzy6P6i" title="Company drew"&gt;100,000&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Between December 2025 and February&#160;28, 2026, Vesicor contributed a
total of $&lt;span id="xdx_900_ecustom--ExtensionFees_c20251201__20260228_zMXntNW6m39e" title="Extension fees"&gt;350,000&lt;/span&gt; as extension fees.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On February 12, 2026, the Company issued a
convertible note to the Sponsor in the amount of up to $&lt;span id="xdx_903_ecustom--WorkingCapital_iI_c20260212_zb4Jlprjcl73" title="Working capital"&gt;300,000&lt;/span&gt;&#160;to
be used for working capital and extension fee purposes (&#x201c;February 2026 Convertible Note&#x201d;). The February 2026 Convertible
Note is unsecured with a 10% annual interest rate commencing on February 12, 2025, and continuing for a period of one year. It is
due on the earlier of the date on which the Company consummates a business combination, or the liquidation date as may be approved
by the Company&#x2019;s stockholders. The February 2026 Convertible Note is convertible solely into the Company&#x2019;s own ordinary
shares at a fixed conversion price of $1.00 per share, which represents one-tenth (1/10) of the Company&#x2019;s $10.00 initial
public offering price per unit. As of February 28, 2026, the February 2026 Convertible Note was fully drawn.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In connection with the Extension, the Company was required to deposit
$&lt;span id="xdx_900_eus-gaap--CustomerDepositsCurrent_iI_c20260122_zRdiihDF5LFh" title="Deposit"&gt;150,000&lt;/span&gt; into the Trust Account for each one-month extension of the Combination Period. The extension payments due on December 22, 2025, January 22, 2026, and February 22, 2026 were funded after their respective due dates. As of the issuance date of these financial statements, the Company
has funded the required extension payments and is current under its amended and restated memorandum and articles of association.&lt;/p&gt;



</us-gaap:SubsequentEventsTextBlock>
    <BKHAU:CompanyDrew
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000873"
      unitRef="USD">100000</BKHAU:CompanyDrew>
    <BKHAU:ExtensionFees
      contextRef="From2025-12-012026-02-28"
      decimals="0"
      id="Fact000875"
      unitRef="USD">350000</BKHAU:ExtensionFees>
    <BKHAU:WorkingCapital
      contextRef="AsOf2026-02-12"
      decimals="0"
      id="Fact000877"
      unitRef="USD">300000</BKHAU:WorkingCapital>
    <us-gaap:CustomerDepositsCurrent
      contextRef="AsOf2026-01-22"
      decimals="0"
      id="Fact000879"
      unitRef="USD">150000</us-gaap:CustomerDepositsCurrent>
</xbrl>
